6. Diseases as ADHD risk factors
Author: Ulrich Brennecke
Review (2024): Dipl.-Psych. Waldemar Zdero
Stressful physical or psychological childhood experiences can be a contributory cause of ADHD.
This article discusses diseases as risk factors for ADHD.
For infants and children:
Exposure to passive smoking, air pollution (especially particulate matter and nitrogen oxides) and various pollutants such as lead, manganese or phthalates is associated with an increased risk of ADHD.
Surgical procedures under anesthesia, neurodermatitis, bacterial infections and concussions are just as much ADHD risk factors as stressful psychological childhood experiences such as trauma, chronic stress or growing up in a home.
Poor bonding behavior of the mother or parents in childhood, stress of the mother in childhood or mental health problems of the parents increase the risk of ADHD in children, as do low socio-economic status, a low level of education or unemployment of the parents.
Earlier school entry and the young age of a child within a class are further risk factors.
During puberty:
A high level of stress during puberty is considered a risk factor for the persistence of ADHD into adulthood.
The % values indicate how much higher the ADHD risk correlates with the respective factor. The figures do not indicate that the respective factor is a causal cause.
- 6.1. Infections and infectious diseases
- 6.2. Craniocerebral trauma (up to + 529 %)
- 6.3. Craniosynostosis (+ 500 %)
- 6.4. Epilepsy (up to + 470 %)
- 6.5. Phenylketonuria (PKU) (+ 375 %)
- 6.6. Sleep-related breathing disorders (SBAS, SDB, SRBD) (up to + 350 %)
- 6.6.1. Sleep-related breathing disorders in general
- 6.6.2. Snoring (up to + 350 %)
- 6.6.3. Constricted turbinate (+ 300 %)
- 6.6.4. Enlarged pharyngeal and palatine tonsils (adenotonsillar hypertrophy) (up to + 275 %)
- 6.6.5. Breathing interruptions during sleep (sleep apnea, OSA, OSAS) (+ 100 %)
- 6.6.6. Upper airway resistance syndrome (UARS)
- 6.7. Gastroesophageal reflux (+ 248 %)
- 6.8. Anorectal malformations (+ 200 %)
- 6.9. Febrile convulsions (+ 168 %)
- 6.10. D-3 insufficiency (+ 157 %)
- 6.11. (Untreated) type 1 diabetes (+ 145 % to + 719 %)
- 6.12. Premenstrual syndrome (PMS) / Premenstrual dysphoric disorder (PMDD) (+ 143 %)
- 6.13. Dystrophinopathy (muscular dystrophy, muscle weakness) (+ 130 %)
- 6.14. Atopic disorders (excess immunoglobulin E)
- 6.15. Hyperthyroidism / hyperthyroidism (+ 70 %)
- 6.16. Nutrition and food intolerances
- 6.17. Early puberty (pubertas praecox) (+ 40 %)
- 6.18. Surgical procedures under anesthesia (+ 25 to 39 %)
- 6.19. Selective immunoglobulin A deficiency (+ 30 %)
- 6.20. Inflammatory bowel disease (IBD) (+ 20 %)
- 6.21. Antihistamines in the first years of life
- 6.22. Lack of sleep
- 6.23. Acne vulgaris
- 6.24. Gut-brain axis, gut bacteria, gut flora
- 6.25. Polycystic ovary syndrome (PCOS)
- 6.26. Anabolic androgenic steroids (AAS)
- 6.27. Glucose-6-phosphate dehydrogenase deficiency (G6PD)
- 6.28. Lipodystrophy (lack of fatty tissue)
- 6.29. Lipid metabolism, fatty acids
- 6.30. Gender diversity
- 6.31. Mitochondrial disorder
- 6.32. Diaphragmatic hernia
- 6.33. Factors without risk increase for ADHD
- 6.34. Factors with risk reduction for ADHD
6.1. Infections and infectious diseases
An infection is the entry of microorganisms (viruses, fungi, bacteria, parasites) into an organism and their colonization and multiplication.
In a broader sense, infectious diseases are also referred to imprecisely as “infections”.1
A higher burden of infection may have a cumulative association with psychiatric disorders beyond what has been described for individual infections. Susceptibility to infections is reflected in the infection burden (the number of specific infection types or sites). An increased burden of infection correlates with an increased risk of2
- ADHD
- ASS
- bipolar disorders
- Depression
- Schizophrenia
- psychiatric diagnoses overall.
A modest but significant heritability was found for the burden of infection (h2 = 0.0221) and a high degree of genetic correlation between it and the overall psychiatric diagnosis (rg = 0.4298). There was also evidence of genetic causality of the overall infection for the overall psychiatric diagnosis.
6.1.1. Infections in the first year of life (+ 16 % to + 77 %)
A register-based cohort study (n = 2,885,662 of which n = 1,864,660 full siblings) found a slight increase of 16% in the risk of ADHD due to infections in the child in the first year of life (ASD + 12%, tics + 12%, mental retardation + 63%), which was lost when twins were controlled for ADHD and tics.3
Severe infections within the first week of life increased the risk of ADHD medicated up to 8 to 14 years of age by 12 %. Meningitis in the first week of life increased the risk of ADHD defined in this way by 77% and the risk of ASD by 105% 4
6.1.2. Bacterial infections (up to + 593 %)
Severe bacterial infectious diseases in childhood or adolescence massively increase the risk of severe mental disorders (HR):5
- ASS: 13,80
- ADHD: 6.93
- ADHD medication use: 11.81
- Tic Disorder: 6.19
- OCD: 3.93
- Bipolar Disorder: 2.50
- Depressive disorders: 1.93
- Antidepressant intake: 2.96
- Mood stabilizer intake: 4.51
- Atypical antipsychotic use: 4.23
- Schizophrenia6
Of the bacterial species examined (streptococci, staphylococci, pseudomonas, klebsiella, haemophilus, mycoplasma, tuberculosis, meningococci, escherichia, chlamydia and scrub typhus), streptococci were associated with the most disorders. ADHD was associated with eight bacterial pathogen infections.5
6.1.2.1. Bacterial meningitis (meningitis) (+ 40 % to + 180 %)
Consequences, children with bacterial meningitis (but not enteroviral meningitis) had an increased risk of ADHD or ADHD medication use:7
- Meningitis in the first 90 days of life:
- ADHD risk 2.8-fold (aHR 2.8, + 180 %)
- ADHD medication intake 2.2-fold
- ASS risk 1.9-fold
- Behavioral and emotional disorders 2-fold
- Learning and intellectual development disorders 4.2-fold
- Meningitis between day 90 and 18 years:
- ADHD risk 1.4-fold (+ 40 %)
- ADHD medication intake 1.5-fold
- Learning and intellectual development disorders 1.5-fold
Tuberculous meningitis showed symptoms of ADHD among 21 people with ADHD.8 With a population prevalence of 8%, this would be a risk increase of 1,150%.
In a more recent study of 78 children with tuberculous meningitis, the same authors found a clinical total problem score in the CBCL (over 70) in only 13.5 % of the children and clinical social problem scores in 20.6 %. In the group, the ADHD score was significantly increased, without any statement being made about the number of people with ADHD.9
The prevalence of Streptococcus agalactiae infection (Group B Streptococcus, GBS) in infants was 0.07%.
GBS has brought about:10
- increased infant mortality (19.41-fold)
- long-term neurological developmental disorders (3.49-fold)
GBS meningitis increased the risk of10
- ADHD
- cerebral palsy
- Epilepsy
- Hearing impairment
- profound and specific developmental disorders
6.1.2.2. Periodontal disease
Periodontal disease is a bacterial inflammation of the gums caused by the bacterium P. gingivalis, which secretes toxins. Periodontal disease and is described as a risk factor for ADHD.11
6.1.2.3. Antibiotics in the first years of life (up to + 33 %)
In a very large study, antibiotic administration in the second year of life increased the risk of ADHD by 20 to 33 % and of sleep problems by 24 to 50 %.12 An even larger study from Korea found a 10% dose-dependent increase in the risk of ADHD, with prenatal and early childhood administration together further increasing the risk13
Another very large study found that the risk of ADHD increased all the more,14
- the earlier the first antibiotic was administered (less than 2 years, 2 to 5 years, 5 to 8 years) and
- the longer the antibiotic treatment lasted (less than 7 days, 7 to 14 days, more than 14 days):
| ADHD prevalence with antibiotic administration at the age of / for the duration of | under 2 years | 2-5 years | 5-8 years |
|---|---|---|---|
| < 7 days | 10.53 % | 7.33 % | 5.18 % |
| 7-14 days | 10.66 % | 8.80 % | 7.25 % |
| > 14 days | 11.47 % | 11.11 % | 8.83 % |
A smaller study found more frequent behavioral difficulties and depressive symptoms in 3 1/2 year old children who had received antibiotics in the first year of life.15 Two other studies found no increased risk of mental disorders when antibiotics were given in the first 1 16 to 217 years of life.
One study found no increase in risk for ADHD, but for asthma, food allergies and allergic rhinitis (hay fever),18 which are known to be associated with an increased risk of ADHD.
The administration of antibiotics in the first three years of life reduces the diversity, stability and composition of the microbiome:19
- reduced frequency of genera
- Bacteroides
- Bifidobacterium
- Lactobacillus
- Staphylococcus
- Sediminibacterium
- increased frequency of
- Members of the Enterobacteriaceae family
- of the genus Enterococcus
During the maturation of the microbiome, several processes of the central nervous system take place, such as synaptogenesis, myelination and synaptic pruning, which can be influenced by microbiome-associated metabolites.19
Exposure to antibiotics in the first years of life increased the child’s risk of: (meta-analysis, k = 30, n = 7,047,853)20
- ADHD: + 33 %
- not significant in studies that used sibling control groups
- Depression: + 29 %
- not significant in studies that used sibling control groups
- ASS: + 19 %
A cohort study found no significant increase in the risk of ADHD or ASD due to antibiotic administration in the first two years of life.21
6.1.3. Viral infections
Powassan flavivirus is transmitted by ticks and in rare cases causes encephalitis in humans. 6 children with Powassan virus encephalitis, diagnosed between the ages of 14 months and 11 years, all suffered permanent neurological sequelae, including22
- Seizures
- Movement disorders
- Behavioral problems
- ADHD
- Learning problems
- States of anxiety
- Sleep disorders
6.1.3.1. Enteroviruses in general (up to + 182 %)
(Non-polio) enteroviruses cause a good half of all cases of aseptic meningitis and are therefore among the most important known causes.23 In addition to encephalitis24, (non-polio) enteroviruses also frequently cause febrile illnesses, hand-foot-and-mouth disease, herpangina, aseptic meningitis and encephalitis, as well as sometimes serious and threatening infections such as myocarditis or neonatal sepsis.
Enteroviruses are being discussed as a possible cause of ADHD.25
One study found an increased risk of ADHD due to mild enterovirus infections (16%) and severe enterovirus infections (182%).26
6.1.3.2. Enterovirus A71 (EV-A71) (+ 200 %)
A longitudinal study of 43 adolescents who had a central nervous system infection with enterovirus A71 (EV-A71) between the ages of 6 and 18 found that 34.9% had ADHD. This more than tripled the risk of ADHD. There was also an increase in autistic symptoms. Other psychiatric diagnoses were not elevated.2728 Another study found ADHD particularly common when the A71 infection was accompanied by cardiopulmonary failure.29
EV-A71 often causes weakness, limb atrophy, seizures, hand-foot-and-mouth disease, encephalitis and reduced intelligence.
6.1.3.3. HIV (+ 150 % to + 1000 %)
A study of children and adolescents with HIV in a stable health condition found ADHD symptoms in 20%30
A study of 100 African children aged 5 years and older with HIV in 2007 found ADHD symptoms in 88 %: 26 % ADHD-I, 38 % ADHD-HI and 24 % ADHD-C. In addition, the prevalence of ODD was 9.5% (teacher assessment) to 12% (parent assessment). 60% of the caregivers were themselves infected with HIV.31
Assuming a population prevalence of 8%, this would result in an increase in ADHD prevalence of + 150% to + 1000%.
6.1.3.4. Zoster encephalitis
In one isolated case, ADHD was mentioned in association with zoster encephalitis.32
6.1.3.5. Human endogenous retroviruses (HERV)
The topic Human endogenous retroviruses (HERV) and ADHD Is presented due to its high heritability in the chapter Development in the article Genetic and epigenetic causes of ADHD - Introduction
6.1.4. Parasitic infections
A study of 100 children with ADHD and 100 healthy children found a correlation of ADHD with:33
- Toxoplasma
- Toxocara
- Cryptosporidium parvum
- Giardia lamblia
- Entamoeba histolytica
No difference was found with regard to Schistosoma (coccidia parasites).
6.2. Craniocerebral trauma (up to + 529 %)
Traumatic brain injuries (TBI) are estimated internationally at 349 per 100,000 person-years. Every second person suffers a traumatic brain injury in the course of their life. Traumatic brain injuries have the highest incidence and prevalence of all common neurological disorders and have been linked in studies to Consequences such as neurodegenerative diseases, cognitive impairment, stroke, psychiatric disorders and increased mortality.34
Craniocerebral trauma can trigger secondary ADHD.35
Brain injury severity correlates with significantly higher ADHD symptomatology. Brain injury-altered default mode network (DMN) morphometry predicted higher ADHD symptomatology 12 months after injury, while salience network (SN) and central executive network (CEN) morphometry were not significant independent predictors.36
A review of k = 24 meta-analyses found a correlation of ADHD risk with previous traumatic brain injury:34
- mild traumatic brain injury: + 18 %, not statistically significant, n = 4,098 subjects
- moderate traumatic brain injury: + 266 %, not statistically significant, n = 117
- severe traumatic brain injury: + 529 %, statistically significant, n = 5,092
The extent to which traumatic brain injuries in ADHD are the result of the increased likelihood of accidents and injuries in ADHD remains an open question.
In one study, 30% of boys and 15% of girls with traumatic brain injury had previous ADHD.37 This study also suggests that girls should integrate physical activity and the provision of resources for dealing with school stress into their rehabilitation program. For boys, cognitive support and strategies for coping with ADHD may be more effective.
ADHD correlated with an increased incidence of brain injury trauma3839 40 and otorhinologic trauma.41
One study examined mild (concussion) and severe traumatic brain injuries before the age of 10. The incidence was 1,156 per 100,000 person-years. At the age of 19, the risk of ADHD was increased by 68% and the risk of learning disability by 29%.42
In more severe cases of traumatic brain injury, the correlation was not statistically significant. In an analysis of cases with possible traumatic brain injury (equivalent to concussion), the result was significant (risk of ADHD increased by 105%, risk of learning disability increased by 42%). The risk in adulthood was particularly increased in the children with the least severe injuries.
In pure correlation studies, however, the extent to which craniocerebral injuries are a consequence of ADHD (increased accident risk) or ADHD is a consequence of craniocerebral injuries (secondary ADHD) is an open question.
Among 1,709 ice hockey players aged 11 to 17, the rate of concussions correlated with higher self-reported and parent-reported scores for attention problems. Only self-reported hyperactivity, not parent-reported hyperactivity, also correlated significantly with concussion. A T-score ≥ 60 combining attention problems and hyperactivity scores (an estimate of probable ADHD) was not significantly associated with incidence of injury or concussion43
A Finnish nationwide retrospective cohort study (1998 to 2018) of pediatric traumatic brain injury patients (n > 126,000) found a significant association between pediatric traumatic brain injury and post-traumatic ADHD medication use during a 20-year follow-up, with the association being particularly pronounced after 4 years.44
Neurodegeneration due to craniocerebral trauma, subsequent neuroinflammation and oxidative stress was assumed to be the pathway of action, which could impair brain development and neurotransmitters and increase the risk of neurodevelopmental disorders.45
6.3. Craniosynostosis (+ 500 %)
Craniosynostosis is a premature ossification of cranial sutures. In one study, the majority of children with craniosynostosis also showed ADHD symptoms. Maternal smoking during pregnancy significantly increased the risk of craniosynostosis.46
Around one in two children who had surgery for metopic synostosis (trigonocephaly or metopic suture craniosynostosis) at 9.5 (± 7.9) months of age showed at least borderline hyperactivity and inattention scores at 10.3 (± 3.5) years of age.47 Older age at surgery was associated with poorer executive functions.
One study found high CAARS-2 ADHD index scores at age 16 and older in 42.6% of those who had had surgery for craniosynostosis as children.48
Craniosynostosis is associated with a significantly increased risk of ADHD symptoms.49
6.4. Epilepsy (up to + 470 %)
Epilepsy is a physical neurological disorder,
One study found a 5.7-fold risk of ADHD in children with epilepsy (41.5% vs. 7.3%). ADHD was usually diagnosed in these children after the epilepsy had subsided and the epilepsy medication had been discontinued.50 Another study found 43.3% of children with epilepsy had ADHD or a learning disorder.51 One study reported 11.2% ADHD and 19.1% ASD in children with epilepsy at age 7.52
Of children with infection-related epilepsy (FIRES), 33.3% showed symptoms of inattention, 53.3% aggression and 20% mood problems.53
In West syndrome (infantile spasms, BNS epilepsy), which occurs in infants, an ADHD prevalence of 15% was cited.54
6.5. Phenylketonuria (PKU) (+ 375 %)
See under Monogenetic causes of ADHD.
6.6. Sleep-related breathing disorders (SBAS, SDB, SRBD) (up to + 350 %)
Other names: Sleep disordered breathing (SDB), sleep related breathing disorder (SRBD).55
Sleep-related breathing disorders (SBAS) as a generic term include, among other things
- primary snoring (pure snoring, without other SBAS)
- Upper airway resistance syndrome56
- obstructive sleep apnea (OSA)5758
- central sleep apnea (CSA)
- sleep-related gas exchange disorders (SAGEA)
SBAS is most common between the ages of 2 and 8 years, presumably due to the relative size of the lymphoid tissue compared to the diameter of the airways59
6.6.1. Sleep-related breathing disorders in general
6.6.1.1. Prevalence of sleep-related breathing disorders
The prevalence of sleep-related breathing disorders (SBAS) was found to be
- Children:
- Children and young people (6 to 17 years)
- 10 %61
- Children and adolescents (5 to 16 years) undergoing orthodontic treatment:58
- SBAS: 10.8 % vs. 5 % in healthy controls
- Snoring: 13.3 %
- Drowsiness: 17.9 %
- Teenagers
- Population
- from 30 to 60 years, AHI from 563
- 9 % for women
- 24 % for men
- 20 %64
- 23.4 % for women65
- postmenopausal 3 to 4-fold increase vs. premenopausal66
- Average age 59 years, AHI from 1565
- 49.7 % for men
- The overall population AHI median was 6.9/h for women and 14.9/h for men65
- from 30 to 69 years (meta-analysis, k = 17)67
- Germany
- 60.1 % AHI from 5
- 32.9 % AHI from 15
- France
- 72.1 % AHI from 5
- 36.3 % AHI from 15
- Austria
- 48.7 % AHI from 5
- 28.4 % AHI from 15
- Switzerland
- 72.4 % AHI from 5
- 36.6 % AHI from 15
- Denmark
- 48.9 % AHI from 5
- 28.5 % AHI from 15
- Sweden
- 17.0 % AHI from 5
- 12.7 % AHI from 15
- USA
- 33.2 % AHI from 5
- 14.5 % AHI from 15
- Germany
- from 30 to 60 years, AHI from 563
- inpatient psychiatric patients
- 23,9 %68
- Prevalence of SBAS (apnea-hypopnea index (AHI), respiratory disturbance index (RDI) or oxygen desaturation index (ODI) from 5/h):66
- 24.0 % to 83.8 % for men
- 9.0 % to 76.6 % for women
- Prevalence of moderate to severe SBAS (AHI, RDI or ODI from 15/h)66
- 7.2 % to 67.2 % for men
- 4.0 % to 50.9 % for women
SBD correlates with hearing problems.
44.8% of children with habitual snoring had a recurring middle ear infection69
Otitis media correlates with SBD and resulting hypoxia.70 Children with otitis media with effusion are more likely to have significant OSA symptoms.71
Middle ear infections are favored by a lack of oxygen.7273747576
Untreated mild SBAS gave itself away:
- in 70.8% of children and adolescents aged 6 to 17 years61
- in 65% of children aged 5 to 9 with mild OSA77
- in 52.9% of children with an AHI of 2 or more by adolescence78
- in 100 % % of children with an AHI of 5 or more up to adolescence; including78
- 50 % partial remission to AHI 2 to 4
- 50 % a remission to AHI below 2
Spontaneous remission is less common in moderate or severe SBAS (AHI 5 or higher). Obesity, high BMI, persistent tonsil hypertrophy, male gender or African-American ethnicity are unfavorable predictors for spontaneous recovery from OSAS.79
6.6.1.2. Oxygen supply for SBAS
TOI: mean nocturnal tissue oxygen index
Unlike in adults, TOI during sleep in children with SBAS does not appear to differ from healthy controls80
In apneas and hypopneas, the decrease in TOI precedes peripheral, systemic desaturation.
TOI falls more sharply
- for apneas than for hypopneas
- during REM sleep than in other sleep phases
- in younger children than in older children
- in children with a high AHI than with a low AHI
A study of 65 children with SBAS examined 540 obstructive and mixed apneas, 172 central apneas and 393 obstructive hypopneas.81
- SpO2 decreased on average by 4.1 % (± 3.1 %)
- TOI decreased on average by 3.4 % (± 2.8 %)
- TOI decreased more strongly
- for apnea (breathing stops) compared to obstructive hypopnea (reduced breathing depth, shallower breathing)
- for moderate to severe SBAS compared to mild SBAS
- in children up to 6 years of age compared to older children
- Explanatory models: lower residual functional capacity, higher oxygen consumption and immaturity of cerebral autoregulation in children80
- TOI declines correlated significantly with the type of event, regardless of the type of event
- SpO2 decreases
- Duration of the event
- Age
A study of 60 children with SBAS analyzed 493 central and 399 obstructive events:82
- Central oxygen supply and heart rate changed more during central events (apneas) than during obstructive events
- Changes were greater in NREM sleep than in REM sleep
- TOI changed more among 3- to 6-year-olds than among 7- to 12-year-olds
- Heart rate changed more in 7- to 12-year-old children than in 3- to 6-year-olds
Two studies found different results:
- Cerebral oxygenation did not correlate with the severity of SBAS. Primary snoring showed significantly worse cerebral oxygenation than mild or severe OSA. Sleep disturbance, male gender, arousal index and NREM sleep correlated with reduced cerebral oxygenation. An increase in mean arterial blood pressure, older age, higher blood oxygen saturation and REM sleep correlated with higher cerebral oxygenation.83
- SBAS in 7- to 12-year-old children was associated with significantly (in primary snoring, AHI max 1) or tendentially (in mild and severe OSA) increased cerebral oxygen (TOI). This could possibly be a compensatory reaction to reduced arterial oxygen saturation during apnea (cerebral autoregulation). In 3- to 6-year-old children, cerebral oxygen was unchanged, regardless of the severity of SBAS. Cerebral oxygen did not correlate with cognitive deficits, but did correlate with behavioral problems in 7- to 12-year-old children. In contrast to cerebral oxygen, oxygen extraction rate (O2-ER or FTOE, which measures tissue oxygen consumption) was lower in all SBAS groups than in controls at all sleep stages. The SpO2 value was the same in all groups.84
In adults, obstructive breathing events (especially during REM sleep and in relation to the duration of the event) were associated with80
- O2Hb decrease
- TOI acceptance
- HHb increase
- tHb increase
In adults, the cerebral oxygen supply changed85
- stronger during obstructive apneas than during obstructive hypopneas
- stronger in severe OSA than in mild or moderate OSA
Repeated drops in oxygen during sleep can damage the respiratory control areas of the brainstem, especially during critical developmental stages, which can cause long-term problems such as unstable breathing, cardiovascular stress or neurological problems.86
Hyperactivity correlated with reduced blood oxygen saturation.87
Hypoxia is a relevant developmental pathway for ADHD.88
Another common developmental pathway of ADHD and SBAS is neuronal inflammation.8990
CO2 and oxygen
Hypocapnia is a reduced partial pressure of CO2 in the arterial blood. Hypocapnia occurs, for example, during hyperventilation due to increased exhalation of CO2.
Hypocapnia causes a narrowing of the brain vessels (cerebral vasoconstriction), which reduces the oxygen supply to the brain despite sufficient O₂ saturation in the blood. A reduced CO2 blood level thus leads to a lack of oxygen in the brain, which is independent of the O₂ saturation of the blood. As CO2 dilates the blood vessels, CO2 deficiency leads to a constriction of the blood vessels and thus to reduced blood flow and, consequently, a reduced oxygen supply.
Hemoglobin binds oxygen in the lungs and transports it to the body’s cells.
Hypocapnia (CO2 deficiency) increases the oxygen affinity of hemoglobin, causing it to bind more oxygen and make it harder to release in the tissues.
Hypercapnia (high CO₂ level) reduces the oxygen affinity of hemoglobin (Bohr effect), which favors oxygen release in the tissues.
In the case of carbon monoxide (CO) poisoning, the CO displaces the CO2 from the blood and indirectly causes a lack of oxygen in the brain via hypocapnia.
6.6.1.3. ADHD with SBAS
One review reported a correlation of ADHD with SBAS of 50%.89
SBAS showed a medium-strong correlation with ADHD symptoms (Hedges’ g = 0.57, 95% confidence interval: 0.36-0.78; p = 0.000001). A high AHI was associated with lower Effect sizes. (Meta-analysis, k = 18, n = 2518)91 Adenotonsillectomy correlated with a decrease in ADHD symptoms 2-13 months after surgery (Hedges’ g 0.43 (SMD; 95% confidence interval = 0.30-0.55; p < 0.001; n = 529).
The risk of ADHD is increased with SBAS:92
- by 1,106 % for moderate and severe sleep problems93
- by 759 % (31.8 % vs. 3.8 % for children and adolescents aged 5 to 16) underwent orthodontic treatment:58
- nocturnal enuresis: 13.6 % vs. 0 %
- Overweight: 18.2 % vs. 2.7 %
- by 393 % for mild sleep problems93
- by 150 % to 200 %94
- by more than 100 %95
- in children with SBAS
- Executive functions deteriorated
- Impaired memory functions
- for 5-year-old children104
- general intellectual abilities impaired
- for 5-year-old children104
- externalizing symptoms96
- Aggressiveness10296
- increased by 110100
- reduced social competence102
- impaired communication skills102
- reduced adaptability102
- Behavioral symptoms99
- internalizing symptoms96
- in 7- to 12-year-old children (CBCL and BRIEF)105
Children with Robin sequence (Pierre Robin sequence, PRS) suffer from a congenital combination of malformations:
- lower jaw too small (micrognathia)
- tongue falling backwards (glossoptosis)
- resulting breathing difficulties due to blockage of the upper airways
- often also have a cleft palate, which exacerbates the breathing and feeding problems
- ADHD symptoms as a possible consequence of breathing difficulties107
- PRS is a common feature of Stickler syndrome, a genetic disorder that causes underdevelopment of the midface
ADHD symptoms resulting from SBD are also referred to as “ADHD-like”, “acquired ADHD”, “secondary ADHD” or “atypical ADHD”108, as the ADHD symptoms in this case do not result from a neurodevelopmental disorder.
View of Ulrich Brennecke, ADxS.org:
Although the name ADHD suggests that it is a disorder, ADHD is actually a syndrome that is only defined by its symptoms. ADHD symptoms can be triggered by many different causes. Since ADHD has so far essentially been treated symptomatically (the typical ADHD medications address the symptom level), a differentiation between “true/primary” ADHD and “false/secondary” ADHD offers the opportunity to measure the necessity and success of treating the causes of “secondary” ADHD against the ADHD symptoms on the one hand, and the risk of considering the proven ADHD treatment forms as inappropriate or inadequate for the treatment of “secondary” ADHD on the other. The latter would be fatal, however.
Even though the DSM now classifies ADHD as a neurodevelopmental disorder, it is doubtful to what extent this follows the mere necessity of classification in the two-dimensional, linear organizational structure of the DSM and to what extent this should define the nature of ADHD. A two-dimensional organization such as the DSM, which does not allow multiple mentions, is forced to classify an item in the most likely or essential place; however, this does not imply that this must be the only correct place. In its rationale for ADHD, the DSM 5 TR is quite contradictory.109
Not only do a variety of environmental factors contribute to ADHD, but even within neurological development there are likely to be many different pathways that lead to ADHD. In addition, it is not possible to clearly differentiate between primary ADHD and the resulting increased risk of comorbidities on the one hand and causes of secondary ADHD on the other. Often enough, an existing (subclinical) primary ADHD may only reach a clinical level when other environmental factors (including illnesses) are added. There are no studies that clearly delineate how many people with “secondary” ADHD already had subclinical ADHD symptoms (in the sense of a predisposition to ADHD) before the secondary cause (such as traumatic brain injury, encephalitis, SBAS) occurred. The question is relevant because not all people with ADHD due to a secondary cause also develop secondary ADHD symptoms. Furthermore, it remains to be seen how many people with ADHD for whom successful treatment of the secondary cause improves the ADHD symptoms, whether this completely eliminates the “secondary” ADHD symptoms or merely reduces them to a subclinical level, where they are still present and have a negative impact on quality of life, but are no longer severe enough to meet the diagnostic criteria.
Studies on the field prevalence of ADHD do not distinguish the causes of the ADHD identified, nor do ADHD diagnoses that are made in (still existing) ignorance of the cause.
With this in mind, it might make more sense to continue calling ADHD ADHD and to differentiate within the ADHD syndrome spectrum based on the different ADHD etiologies and contributing factors.
Among children ages 4 to 12 who attended a dental clinic, SBAS correlated with a greater than 7.35-fold risk for ADHD medication, a 40% increased risk for asthma medication, and a 12.5-fold risk for other medications59
- SBAS correlated further with:59
- Allergies: 4.9-fold
- Developmental disorders: 4.94-fold
- Behavioral disorders: 3.94-fold
- Difficulty sleeping through the night: 3 to 6 times
- Mouth breathing: 4.7- to 5-fold
- Snoring: 3-fold
- 70% of children with SBAS snore frequently110
- fewer birth complications suffered during their own birth
- 83.3% of parents reported that they snore, compared to 52.2% of parents of children without SBAS
- ADHD medication use correlated low to moderate with mouth breathing (Phi = 0.216)
- Mouth breathing correlated moderately to strongly with snoring (Phi = 0.386, p < 0.001).
Polysomnography studies found a correlation of ADHD and sleep-related disorders only in terms of more movements at night.111112 Polysomnography is a sleep laboratory examination with measurement of brain waves (EEG), eye movements (EOG), heart activity (ECG), breathing, oxygen saturation, muscle activity (EMG) and body position.
A study reports increased snoring and breathing interruptions in children with Down syndrome.113 Downs syndrome is associated with an ADHD rate of 50%. More on this at Monogenetic causes of ADHD.
A genomic correlation was found between ADHD and insomnia, daytime napping, daytime sleepiness, snoring, daytime sleepiness, short sleep duration and long sleep duration. Insomnia, daytime sleepiness and snoring shared genes with ADHD that are involved in neurobiological functions and regulatory signaling pathways114
The upper quartile for the SBAS apnea-hypopnea index (AHI greater than 20.6/h) correlated (independently in each case) with65
- metabolic syndrome (OR 2.80)
- Diabetes (OR 2.00)
- Depression (OR 1.92)
- High blood pressure (OR 1.60)
Children with ADHD are more likely to show SBAS symptoms.115
6.6.1.4. Adenotonsillectomy for SBAS and changes in ADHD symptoms
Children 6 to 12 years of age with SBAS showed a correlation between lowest blood oxygen saturation and performance on the Modified Wisconsin Card Sorting Test. Adenotonsillectomy significantly improved the apnea-hypopnea index (AHI), and improved mean scores on most neurocognitive and behavioral measures, although residual deficits persisted at 6 months. However, almost half of the children continued to suffer from SBAS. A baseline AHI > 5/h and complete improvement in SBAS (postoperative AHI < 1/h) correlated with improvement in more subscales than a baseline AHI < 5/h or incomplete improvement in SBAS. Impairment of neurocognitive performance in SBAS appears to be due to hypoxemia rather than frequency of SBAS events.116
Children with SBAS who had undergone adenotonsillectomy117
- showed before the operation compared to those not affected
- more common ADHD (DSM-IV)
- frequent hyperactivity
- more inattention in cognitive tests
- more sleepiness in the Multiple Sleep Latency Test sleepier
- showed significant improvements in all values after the operation and no longer differed from those who were not affected
- the improvements could not be predicted by polysomnographic measurements before the operation
Among 64 children with SBAS (3 to 12 years), there was a significant improvement in quality of life 4 years after adenotonsillectomy, but no improvement in behavior after CBCL.118
Among 20 children with OSA (3 to 13 years), there was a significant improvement in ADHD symptoms, behavior and snoring 4.5 years after adenotonsillectomy.119
Among 54 children with sleep-related gas exchange disorders (SAGEA), surgical tonsillectomy and adenoidectomy resulted in a statistically significant improvement in school performance, while this remained unchanged in children without the surgery.120
Children with mild (apnea-hypopnea index (AHI) below 6 or apnea index (AI) below 1) SBAS (AHI average 3.1) and children with OSA (AHI from 5 or AI from 1) (AHI average 25.3; 10 to 48) showed no differences in BASC scores before adenotonsillectomy. After surgery, both groups showed a significant improvement in the behavioural symptom index, as well as in the BASC scales for atypicality, depression, hyperactivity and somatization.121
Observational differences: symptom perception vs. polysomnographic measurement
Several studies have observed that the symptom severity reported by parents or teachers correlates only to a limited extent with the results of polysomnographic measurements.
SBAS in children aged 5 to 17 years showed for the five domains of executive functions (meta-analysis k = 14, n = 1697)122
- with polysomnographic measurement
- 0.43 Generativity (SMD)
- the other four areas of executive functions (vigilance, inhibition, working memory, shifting) were not significantly
- for questionnaire survey
- for all three measured areas of executive functions significantly from SMD 0.64 to 1.06
- 0.64 Inhibition (SMD in the parent report)
- 1.06 Working memory (SMD in the parent report)
- 0.86 Task change (SMD in parent report)
- for all three measured areas of executive functions significantly from SMD 0.64 to 1.06
- Severity of SBAS did not affect executive functions
Children aged 7 to 12 years who were divided into control group (N = 34) based on nocturnal polysomnography; primary snoring (PS: N = 55), mild obstructive sleep apnea (mild OSA: N = 22) and moderate to severe OSA (MS OSA: n = 16) showed deficits in working memory in the Behavior Rating Inventory of Executive Function (BRIEF) at all levels of SBAS severity. While a computer test (recognition of playing cards, CogHealth) found no difference between SBAS and controls, mild OSA showed significantly poorer performance than the group with primary snoring. Parents of children with primary snoring, on the other hand, reported stronger working memory deficits than the objective measure.123
Among children aged 5 to 9 years with adenotonsillar hypertrophy and diagnosed sleep apnea, 42% no longer met the diagnostic criteria for sleep apnea after 7 months without surgery. This remission was statistically significantly more frequent with lower AHI, better oxygen saturation, smaller waist circumference, higher positioned soft palate, smaller neck circumference and non-black skin color. However, of the 167 children with baseline PSQ scores ≥ 0.33, only 15% achieved symptomatic remission. This was predicted by low PSQ and PSQ snoring subscale scores, absence of habitual snoring, loud snoring, observed apnea or smoking in the home, higher quality of life, fewer symptoms of ADHD, and female gender. Only lower PSQ and snoring scores were independent predictors.
In summary, a wait-and-see approach to polysomnography is often associated with an elimination of the OSAS diagnosis, but rarely with a significant improvement in symptoms.124
Children aged 3 to 5 years with SBD showed SBD at a follow-up examination 3 years later:125
- 60% of the children treated showed a cure for SBAS
- 40% of untreated children showed a cure for SBAS
- cured was defined as: OAHI of max. 1/hour and no snoring on polysomnography and no report of habitual snoring by parents
- no cognitive differences between “cured”, “not cured” and “control group”
- Behavioral function significantly worse in children with initial SBAS diagnosis compared to controls, regardless of cure
- OAHI change did not predict cognitive or behavioral outcomes
- Reduction in nocturnal arousals, independent of complete recovery, correlated with improved alertness and less aggression
6.6.2. Snoring (up to + 350 %)
Primary snoring (snoring without OSA) differs from obstructive sleep apnea in the number of hypopneas per hour.
Primary snoring is assumed with an AHI of max. 1, OSA with an AHI of more than 1.
6.6.2.1. Prevalence of snoring
Population prevalence of snoring
- Children from 4 to 6 years126
- 24.9 % occasional snoring
- 15.2 % habitual snoring
- Children from 5 to 7 years
- 7.7 % Snoring in the parental report127
- Children from 2 to 8 years 10 %128
- Children from 6 to 12 years: 5.7 %129
- Boys 7.5 %
- Girls 3.8 %
- from 6 to 9 years higher than from 10 to 12 years
- Children from 7 to 13 years130
- 38,9 %
- Habitual snoring 3.5 %
- most frequently from 7 to 8 years
- Children aged 2 to 14 who had a clinic appointment
- 16 % habitual snoring131
- Children aged 14:
- Children and young people from 2 to 18 years: 10 %134
- Young people 9.7 %62
Habitual snoring in primary school children (4 to 6 years) correlated with126
- Passive smoking (odds ratio (OR) = 1.77, + 77 %),
- Pets at home (OR = 0.58, minus 42 %)
- Nitrogen dioxide (NO2) exposure in winter increases snoring risk compared to low exposure (<30 micrograms/m3)
- 2.5-fold (+ 150 %) for medium (30-60 µg/m3) NO2 exposure
- 4.5-fold (+ 350 %) at high exposure (> 60 µg/m3)
6.6.2.2. Snoring and ADHD symptoms
Habitual snoring predicted hyperactivity in children 4 years later (+ 340 %, OR 4.4), as did loud snoring (+ 350 %, OR 4.5). The 25% heaviest snorers had a 5.3-fold risk of hyperactivity 4 years later (+ 430%). Sleepiness was associated with a 3-fold risk (+ 200 %), sleep-related breathing disorders with a 4-fold risk (+ 300 %) of hyperactivity 4 years later.136
The prevalence of ADHD was doubled (+100%) in children who snored occasionally or often.133
In contrast, a study of n = 512 snoring children and adolescents (70% of whom were overweight or obese and 35% with an increased obstructive AHI of more than 3/h) found that of the snoring children137
- 36 % showed hyperactivity/impulsivity
- 24 % showed emotional dysregulation
- Surprisingly, it was not the reduced oxygen supply due to sleep apnea that correlated with hyperactivity/impulsivity or emotional dysregulation, but rather the volume of snoring
Snoring in various forms correlated with 30% increased scores in inattention, hyperactivity and overall ADHD according to the Korean ADHD-RS in a large study of children aged 6 to 12 years:138
- Snoring more than half the time
- Always snore
- Loud snoring
- Heavy or noisy breathing
In children aged 5 to 7 years without a diagnosis of ADHD and without hyperactivity, frequent snoring correlated with139
- Attention problems
- Social problems
- Anxiety symptoms
- Symptoms of depression
- Poorer cognitive scores
Children aged 6 to 10 years with habitual snoring who had undergone polysomnography (PSG) showed increased levels of140
- Hyperactivity (ADHD Rating Scale)
- Inattention (ADHD Rating Scale)
ADHD symptoms depended on the level of snoring in children aged 6 to 12 years:129
- frequently snoring children
- 31.3 % Attention deficit
- 18.2 % Hyperactivity/impulsivity
- occasionally snoring children
- 16.2 % Attention deficit
- 9.9 % Hyperactivity/impulsivity
- non-snoring children
- 13.9 % Attention deficit
- 8.8 % Hyperactivity/impulsivity
Children aged 2 to 14 who had a clinic appointment showed:131
- Hyperactivity: 22 % with habitual snoring vs. 12 % with non-snoring
The level of snoring, but not the AHI, correlated in children aged 4 to 10 years with141
- Hyperactivity (CPRS-R)
- Inattention (CPRS-R)
- Cognitive performance (NEPSY, DAS)
- Internalizing symptoms (CBCL)
- Externalizing symptoms (CBCL)
- Understanding instructions (NEPSY)
- The correlation between snoring and AHI was weak (rs = 0.24).
Among snoring children aged 5 to 7 years, an AHI of 5 or more in the NEPSY correlated with poorer scores in terms of142
- Inattention
- Executive problems
Habitual snoring in children and adolescents correlated with hyperactivity.130143
A study of n = 405 children aged 4 to 9 years found clinically relevant hyperactivity in 15.5 % compared to 5.3 % in controls (+ 188 %). In addition, a high probability of hyperactivity was found in 11.1 % compared to 4.1 % in the controls (+ 170 %).
One study found 43% higher levels of hyperactivity and 25% higher levels of inattention in children who snored. Both scores improved significantly with adenotonsillectomy.101
Habitual snoring in primary school children correlated with:
- Hyperactivity increased144, 180% more frequently145, 140% more frequently 146
- Inattention increases144, 340% more frequently145, 300% more frequently146
- Oppositional behavior increases144
- Behavioral problems 180% more frequent 146
- Emotional problems 450% more frequent146
- Problems with peers 870% more frequent 146
- Daytime sleepiness 970 % more frequent145
- UARS/OSA at 25 %145
- poorer school performance145
- Mathematics + 160 %
- Natural sciences + 230 %
- Spelling + 150 %
The changes were 140% more frequent regardless of intermediate hypoxia.146 The behavioral problems improved when the snoring disappeared.
In adolescents, frequent snoring correlated with a 130% increased risk of ADHD.147
Using Mendelian randomization, one study found no statistically significant association between sleep apnea or snoring and ADHD. ADHD correlated significantly with shorter sleep duration.148
Children with ADHD snored more frequently than non-affected children.149150151
- 77.8% of children aged 6 to 14 years with ADHD who underwent polysomnography snored heavily. Obstructive sleep apnea syndrome (OSAS) was found in 50.0 %.152
- 40% of children with ADHD snored louder than 60 dB at times, compared to 28% of controls.153
- 33% of children with ADHD (DSM-IV) snored, compared to 9% to 11% of those without134
- 26.7 % of children aged 5 to 13 with hyperkinetic syndrome snored according to154
- 21% of all children with ADHD (average age 8.9 years) snored155
Adolescents who had been diagnosed as children with ADHD (DSM-IV),156
- and whose ADHD persisted in adolescence snored 57.9 % of the time. Snoring was therefore 3.5 times more common than in those not affected (+ 250%)
- and whose ADHD did not fully persist in adolescence (subclinical ADHD) snored 43.4 % of the time, which is 2.0 times as often as those not affected (+ 100 %)
- Snoring was thus 80% more common in persistent ADHD than in subclinical ADHD.
- 28.3 % of non-affected controls were sharp
ADHD at the age of 5 correlated with a 32% higher risk of snoring at the age of 14157
Among adolescents aged 10 to 17 years, 50.7% of persons with ADHD-I and ADHD-C snored, compared to 33.2% of non-affected persons158 In contrast, a small study found an increased prevalence of snoring only among persons with ADHD-HI159
Infrequent snoring in children also correlated with increased ADHD symptoms.160
Methylphenidate improved snoring and bruxism in ADHD-I after 6 months.161
6.6.2.3. Adenotonsillectomy for snoring and changes in ADHD symptoms
Adenotonsillectomy improved snoring in children:
- Attention/concentration by 42162
- verbal fluency by 92 %162
- Learning/memory by 38 %162
- executive functions by 52 %162
- general intellectual abilities by 33162
- Inattention by 21 %162
- Hyperactivity by 21 %162
- neurocognitive performance not163
See also under Differential diagnosis: Primary organic disorders
6.6.3. Constricted turbinate (+ 300 %)
Hypertrophy of the inferior turbinate can cause sleep-related breathing disorders (SBAS) and ADHD symptoms.
The inferior turbinates cause up to 50% of the total resistance of the nasal airways.164 Up to 20% of the population suffer from chronic nasal congestion due to hypertrophy of the turbinates.165
Chronic hypertrophy of the turbinates, which is often caused by allergic rhinitis (hay fever) or chronic rhinosinusitis, can significantly impair nasal breathing even without adenotonsillar pathology.166
A retrospective cohort study of n = 326 children aged 3 to 17 years (mean 9 years, 65% boys) who underwent inferior turbinate reduction (ITR) between December 2020 and May 2023 (in isolation or in combination with adenotonsillectomy, septoplasty or functional endoscopic sinus surgery) found ADHD-like symptoms in 32.5% of participants before surgery. In these, parents reported 12 months after surgery:166
- 89.6 % improved nasal breathing
- 84.0 % Relief of SBAS symptoms
- 48.1 % improvement in ADHD symptoms, which correlated significantly with an improvement in nasal breathing
Assuming an ADHD prevalence of 8% in children and assuming that ADHD symptoms were equivalent to an ADHD diagnosis, 32.5% would have a 300% increased risk of ADHD.
One study found a significant improvement in sleep quality but no improvement in ADHD symptoms with nasal septum surgery (straightening of a curved nasal septum).167
6.6.4. Enlarged pharyngeal and palatine tonsils (adenotonsillar hypertrophy) (up to + 275 %)
**Adenotonsillectomy: Surgical removal of the palatine tonsils (tonsils) and pharyngeal tonsils (adenoids), often due to recurrent infections or enlargement leading to breathing problems such as obstructive sleep apnoea. Common standard treatment for children with moderate to severe sleep apnea syndromes. Can improve breathing problems, behavioral problems and daytime sleepiness.
**Adenotomy: Surgical removal of only the pharyngeal tonsils (adenoids, infantile adenoids)
**Tonsillectomy: Surgical removal of only the palatine tonsils (tonsils, cervical tonsils)
Adenotonsillar hypertrophy is the most common factor for SBAS in children.57168
Chronic adenotonsillar hypertrophy can lead to various types of breathing-related sleep disorders, from loud snoring to severe obstructive sleep apnea. Chronic adenotonsillar hypertrophy can affect sleep architecture, e.g. increased arousal during sleep, increased REM sleep latency, decreased REM sleep, decreased sleep efficiency
or shortened sleep duration.169170
Normally, adenoid enlargement occurs particularly in the first years of life and usually - but not necessarily - disappears during late childhood.
The loss of nasal function during breathing can promote chronic inflammation of the upper respiratory tract.
6.6.4.1. Prevalence of adenotonsillar hypertrophy
Population prevalence of adenotonsillar hypertrophy
The population prevalence of adenoid hypertrophy was
- for children
- 34,5 %171
- for children and adolescents
- for adults
- 26.28 %, regardless of gender173
- 14.6 % Grade 1
- 8.2 % Grade 2
- 3.6 % Grade 3
- 26.28 %, regardless of gender173
- Tonsil/adenoid hypertrophy was found in children with ADHD (6 to 12 years) at174
- 30.2 % of those with sleep disorders
- 13.8 % of those without sleep disorders
6.6.4.2. Adenotonsillar hypertrophy and ADHD symptoms
The prevalence of ADHD in children with adenotonsillar hypertrophy was (compared to an assumed prevalence of 8%)
In n = 35 children aged 5 to 12 years with adenotonsillar hypertrophy and ADHD (DSM-IV), adenotonsillectomy** Six months after surgery:179
- 57.8 % less ADHD-C (22.9 % after surgery compared to 54.3 % before surgery).
- Inattention significantly reduced
- Hyperactivity significantly reduced
- combined ADHD symptoms significantly reduced
Children with ADHD from 6 to 12 years of age had a 2.71-fold risk of adenotonsillar hypertrophy.174
Impairments in cognitive function and behavior correlated with snoring, sleep efficiency, sleep latency and ethnicity, but not with tonsil size, in children aged 6 to 12 years. Snoring correlated better with the deficits than the number of apnea and hypopnea episodes per hour of sleep.180
6.6.4.3. Adenotonsillectomy for adenotonsillar hypertrophy
Adenotonsillectomy in children with ADHD and adenotonsillar hypertrophy
- resolved ADHD in 50% at 6 months after surgery. ODD remained unchanged.175
- resolved ADHD in 70% at 6 months after adenotonsillectomy181
- (even more pronounced after 6 months than after 3 months):182
- Oppositional behavior
- Inattention / cognitive symptoms
- Hyperactivity
- Overall ADHD symptoms
- improved in children with ADHD, but also in children without ADHD183
- Oppositional behavior
- Inattention / cognitive symptoms
- Hyperactivity
- Overall ADHD symptoms
- In a long-term follow-up, the values did not deteriorate after 2.4 to 3.6 years after the surgery, and remained significantly better than the values before the surgery - except for the ADHD total index.184
- improved ADHD symptoms more than treatment with MPH without surgery, with symptoms dropping almost to the level of non-affected patients after surgery185
- in children and adolescents with SBAS and ADHD (according to DSM-IV) significantly improved the values of 186187178188189
- Hyperactivity
- Inattention
- ADHD total score
Similarly, 54% of children with enuresis no longer had enuresis after the operation.187
In 26.3% of children (3 to 7 years) who underwent adenotonsillectomy, sleep apnea (AHI over 2) was still present after one year.190
6.6.5. Breathing interruptions during sleep (sleep apnea, OSA, OSAS) (+ 100 %)
Sleep apnoea (obstructive sleep apnoea syndrome, OSA, OSAS) is measured using the apnoea-hypopnoea index (AHI). This indicates the number of complete pauses in breathing (apneas) and partial pauses in breathing (hypopneas) per hour of sleep. An AHI below 5 is considered normal, 5 to 14 indicates mild sleep apnea, 15 to 30 indicates moderate sleep apnea and more than 30 indicates severe sleep apnea.191
6.6.5.1. Prevalence of OSA
Prevalence of sleep apnea
The population prevalence of sleep apnea was put at
- 2 to 4 %
- Children
- Young people: 2.5 to 6.1 %62
- from 30 to 60 years, SHI from 5 and hypersomnolence during the day63
- 2 % for women
- 4 % for men
- from 30 to 60 years, SHI from 5 and hypersomnolence during the day63
- middle age: 4 to 5 %64
- in some recent studies at 13 % for men and 6 % for women
- for type 2 diabetics
- 65% (AHI 5 or higher), 26% moderate (AHI 15 or higher) or severe OSA194
- for Down syndrome
OSA in children with ADHD (6 to 12 years):174
- 46.6% of children with ADHD had suspected OSA based on a PSQ > 7 (Pediatric Sleep Questionnaire)
- 23.4% of children with ADHD aged 6 to 12 years showed OSA on respiratory polygraphy
- Compared to an assumed child population OSA prevalence of 8%, this is a 200% increased risk of OSA
- 93.5% showed clinically significant sleep problems according to the Children’s Sleep Habits Questionnaire (CSHQ)
OSA correlates with hypoxia, arousal states during sleep and negative fluctuations in intrathoracic pressure. Consequences can be79
- Stress on the cardiovascular system.
- peripheral vasoconstriction
- intermittent rise in blood pressure (increased blood pressure variability)
- increased heart rate
- reduced heart rate variability
- Treatment of OSA improves cardiovascular system factors79
- Activation of the sympathetic nervous system
- elevated urine catecholamine levels
- increased oxidative stress
- systemic inflammation
- endothelial dysfunction
- reduced nocturnal baroreflex amplification
- consequences of increased blood pressure fluctuations
- subclinical abnormalities of cardiac structure and function that can only be detected by ECG
- Enuresis
- improved by OSA treatment
- Growth restriction
- Size and weight
- improved by OSA treatment
- Excessive daytime sleepiness
- improved by OSA treatment
- Limited quality of life
- improved by OSA treatment
- ADHD (see below)
- Hyperactivity
- Inattention
- cognitive impairments
- stressed executive functions
- improved by OSA treatment
The prevalence of insomnia in OSA is between 39% and 55%194
6.6.5.2. ADHD symptoms with OSA
Breathing interruptions during sleep in children can cause symptoms that resemble ADHD.197
It remains to be seen whether breathing interruptions during sleep can cause such stress that they can contribute to ADHD through epigenetic changes, or whether they merely cause symptoms that are similar to those of ADHD. In the latter case, people who did not previously have ADHD and who have developed ADHD (similar) symptoms as a result of breathing interruptions during sleep should see these symptoms disappear completely once the breathing interruptions during sleep have been eliminated. We are not yet aware of any studies on this.
In children with OSA, the prevalence of ADHD was doubled (+100%).133
Children aged 6 to 10 years with OSA who had undergone polysomnography (PSG) showed increased levels of198
- Hyperactivity (ADHD Rating Scale)
- Inattention (ADHD Rating Scale)
Among 110 boys aged 6 years, SBAS correlated with hyperactivity but not with inattention.199
Children from 4 to 12 years of age with polysomnography-diagnosed mild or moderate OSAHS showed compared to healthy controls200
- FIQ, VIQ and performance IQ (PIQ) scores did not correlate with AHI, OAHI and lowest nocturnal SO2 level
- under 6 years
- significantly lower scores on overall IQ (FIQ), verbal IQ (VIQ), comprehension test and visual analysis
- the cumulative time of SO2 below 90 % (p = 0.046) and the percentage of cumulative time of SO2 below 90 % in total sleep time (p = 0.034) correlated significantly negatively and significantly with the PIQ
- from 6 years significantly lower VIQ and classification test results in children with OSAHS significantly lower
Children with ADHD have a significantly higher AHI (apnea-hypopnea index). (meta-analysis, k = 16, n = 1,360)201 A case study of 3 adults with ADHD and OSA drew attention to the topic at an early stage202
Children with ADHD without OSA aged 6 to 13 years showed unremarkable sleep on polysomnography.203
Children with OSA and ADHD showed compared to children with OSA without ADHD:204
- AHI values increased
- Increased blood oxygen saturation
- IL-4 increased
- IL-12 increased
- IL-13 increased
- transforming growth factor (TGF)-β significantly lower
- Increased dopamine levels (presumably peripheral)
- Noradrenaline levels significantly lower (presumably peripheral)
- Increased serum leptin levels
- Adiponectin reduced
- Resistin reduced
6.6.5.3. Adenotonsillectomy for OSA and changes in ADHD symptoms
Children with OSA due to grade 3 and 4 adenotonsillar hypertrophy showed cognitive dysfunction (worse NESPY score). Adenotonsillectomy improved these and reduced serum cytokine levels of tumor necrosis factor-α (TNF-α), interleukin (IL)-6 and 1β. Lifestyle interventions worked satisfactorily for mild OSAS and minimal cognitive dysfunction and improved the results of adenotonsillectomy before surgery. Among the subjects, 33.5% were overweight and a further 55.8% had obesity. Tonsil hypertrophy was grade 4 in 27.7 %, grade 3 in 44.2 %, grade 2 in 27.2 % and grade 1 in 0.9 %. Adenoid hypertrophy was zero in 5.4 %, grade 1 in 5.7 %, grade 2 in 41.1 %, grade 3 in 36.2 % and grade 4 in 11.5 %. Neither tonsil hypertrophy nor adenoid hypertrophy correlated statistically significantly with the OSA AHI score. Severe OSA tended to increase adenoid hypertrophy.205 Of the 181 patients with grade 3 or 4 adenotonsillar hypertrophy, 19 underwent adenoidectomy, 76 underwent tonsillectomy and 86 underwent adenotonsillectomy. Tonsillectomy or adenotonsillectomy was significantly more frequently required for severe OSA. Cognitive performance (NEPSY score) was significantly worse in severe OSA than in mild OSA before treatment. During follow-up, cognitive performance improved in 76.7% of subjects with mild OSA, 84.1% of subjects with moderate OSA and 87.8% of subjects with severe OSA.
The reduced serum levels of inflammatory cytokines indicate the involvement of OSA in inflammatory processes.
In children aged 5 to 9 years and OAI (apneas per hour of sleep) of 1 to 20 or AHI (apneas or hypopneas per hour of sleep) of 2 to 30, adenotonsillectomy correlated with slight improvements (SMD Cohen’s d, 0.20 to 0.24) with respect to206
- non-verbal thinking
- Fine motor skills
- selective attention
A study in children with OSA without prolonged blood oxygen desaturation found a trend (SMD 0.15) but not statistically significant improvement in attention and executive function scores on the Developmental Neuropsychological Assessment with early adenotonsillectomy compared to a wait-and-see approach with supportive treatment. However, early adenotonsillectomy correlated with significantly greater improvements compared to wait-and-see observation in terms of77
- Behavior
- Quality of life
- polysomnographic findings (79% normalization compared to 46%)
- ADHD symptoms (SMD 0.28 in the parent rating and SMD 0.29 in the teacher rating of the Conners Rating Scale)
Children with OSA showed
-
Before an adenotonsillectomy
- Significantly poorer cognitive performance compared to controls; postoperatively, the values no longer differed.207
-
After an adenotonsillectomy
- A statistically insignificant tendency towards better scores on the Homework Performance Questionnaire (HPQ-P).208
Among 52 children with OSA (age 7.1; 2.5-14.9 years) (AHI 16.2; 5.0-88.0), mean BASC-t scores for all behavioral scales and composites were above 50 before adenotonsillectomy. After adenotonsillectomy, there was a significant improvement for210
- Aggression
- Atypicality
- Depression
- Hyperactivity
- Somatization
Elevated levels of IL-6, IL-8, IL-17, IL-18, MIF, Hs CRP, TNF-α, PAI-1 and leptin correlated with OSA, of which only IL-18 did not also correlate with BMI, while IL-23 also correlated with BMI.211
Children aged 6 to 12 years with a low AHI (1 to 4) showed no statistically significant impairment of neuropsychological functions (intelligence, verbal and non-verbal reasoning, attention, executive functions, memory, processing speed and visual-motor skills).212
6.6.6. Upper airway resistance syndrome (UARS)
While OSA is associated with apneas (pauses in breathing) and hypopneas (decreased depth of breathing) that last more than 10 seconds (2 to 3 breaths) and are often accompanied by a drop in blood oxygen and an increase in CO2, upper airway resistance syndrome (UARS) is associated with shorter pauses in breathing.56
Boys are more frequently affected, as testosterone leads to muscle growth. While the craniofacial skeleton forms in early childhood, the testosterone-induced muscle growth of the tongue and throat muscles, among others, does not begin until puberty in a spatial structure that is already defined by the bone structure.
In addition to a genetic predisposition, increased nasal resistance is favored by various environmental factors:56
- Allergies
- Infections
- abnormal size of the nasal lymphatic tissue (which in turn is promoted by allergies and infections of the airways or ears)
Newborns show:56
- increased breathing effort, longer than four breaths, measured by the expiratory rate
- a sudden increase in respiratory effort with a negative peak end-expiratory effort immediately followed by a cessation of diaphragmatic movement of two or more breaths. These are not central apneas, but a reaction to the sudden increase in respiratory effort
- an abrupt increase in breathing rate over 4 or more breaths without an increase in breathing effort. The increase in respiratory rate serves as compensation for the decrease in
Tidal volume - the events occur without a significant drop in oxygen saturation (pulse oximeter) or oxygen tension (transcutaneous P o 2 electrode)
Infants show:56
- clearer nocturnal symptoms
- Difficulty sleeping through the night possible, crying on waking at night
- Thumb sucking can encourage repositioning of the tongue, the combination of pressure and sucking can reduce the initial resistance to inhalation, especially
for mouth breathing - rarely also speaking in sleep
- Restless sleep
- Sweating during sleep, the extent of which correlates with fluctuations in nasal resistance
- Head may be hyperextended
- Sleeping position more often on the stomach, sometimes every night with the knees under the stomach and the bottom up
- at least temporary mouth breathing
- intermittent snoring
- Enuresis is possible
- long head with narrow jaw favors UARS
Often accompanied by:
- more frequent earaches
- frequent respiratory infections
- Respiratory allergies
Even at this age, behavioral problems can be the result:56
- Attention problems
- Hyperactivity
- rebellious behavior
- inexplicable aggressiveness towards peers
- considerable shyness
- Fear
Schoolchildren and teenagers show:56
- frequently:
- Hyperactivity
- Attention deficit disorders
- Poor performance at school
- sometimes mental absence (teacher’s report)
- Daytime tiredness
- Normal weight to underweight
- possible:
- Drowsiness
- Difficulties with peers
- Aggressiveness
- mild autonomic dysfunction
- cold hands and/or feet
- Drowsiness or dizziness when bending down or standing up abruptly
.
- Sleep behavior:
- frequent snoring
- continuous movements
- Difficulties getting up in the morning
- Teenagers often difficult to wake up in the morning
- late for school / training
- shifted chronobiorhythm (eveningness)
- Daytime tiredness
- Exhaustion at the end of the day
- Fear during the day
- Teenagers often difficult to wake up in the morning
- night sweats
- morning headaches
- Enuresis
- Sleep conversations
- Sleepwalking
- especially with teenagers
- sometimes with nightmares or sleep disorders
- Teeth grinding
Treatment options for children:
- Tonsillectomy
- additional adenoidectomy if necessary
- Orthodontics if required:
- slow maxillary distraction
- maxillary and/or mandibular expansion
- Braces
- Removing wisdom teeth with a narrow jaw
6.7. Gastroesophageal reflux (+ 248 %)
Gastroesophageal reflux disease (GERD) increased the risk of ADHD at 3 to 5 years of age (HR = 3.48) (registry study, n = 631,695).213
ADHD increases the risk of GERD.214
It is not clear from the abstract whether it is really about GERD in the children themselves. The full text of the study was not yet available to us.
6.8. Anorectal malformations (+ 200 %)
Anorectal malformations are congenital malformations of the anus and are associated with an increased risk of ADHD, depression and anxiety disorders.215
6.9. Febrile convulsions (+ 168 %)
According to clinical and animal studies, febrile convulsions have detrimental effects on neurodevelopment, which can lead to ADHD, increased susceptibility to epilepsy, hippocampal sclerosis and cognitive decline in adulthood217
Febrile convulsions in children increased the risk of ADHD by
6.10. D-3 insufficiency (+ 157 %)
A meta-analysis of 10,334 children and adolescents found a 2.57-fold risk of ADHD with a D3 insufficiency (between 10 and 30 mg/nl in blood plasma).221
Comprehensive information on vitamin D3 can be found at Vitamin D In the article Vitamins for ADHD in the section Vitamins, minerals, dietary supplements for ADHD in the chapter Treatment
6.11. (Untreated) type 1 diabetes (+ 145 % to + 719 %)
An increased risk of ADHD was found in people with ADHD:222
- 8.19-fold ADHD risk (HR = 8.19)223
- 2.45-fold risk of ADHD in non-treated people in a study of people with ADHD with and without insulin pump treatment, where ADHD was considered a risk factor for inconsistent diabetes treatment224
- 1.68 times higher risk of ADHD (4.2 % vs. 2.5 %)225
- Among people with ADHD 1, 15.9% had an existing ADHD diagnosis and a further 31.9% met the ADHD criteria of the ASRS.226 Assuming an ADHD prevalence of 8%, this would be a doubling (+100%). However, the test subjects were those who had responded to the ASRS sent to them, so a bias towards an inflated ADHD rate can be expected here.
- Children with diabetes have a higher prevalence of ADHD, ASD, seizures and depression, and tend to have lower IQ scores and poorer academic performance227
One study found no evidence of causality of autoimmune diseases such as diabetes 1 for ADHD.228
In addition to regulating blood sugar levels, insulin also has tasks in the brain:227
- acts on IR in brain astrocytes, which affects dopaminergic signaling and can thus modulate cognition and mood
- increases the number of NMDAR channels in the cell surface membrane through regulated exocytosis
- NMDARs control the entry of calcium ions into the cell and trigger long-term potentiation (LTP), which is associated with learning and memory processes
- influences the activity of AMPA receptors in the hippocampus
- this leads to LTD in the CA1 region, downregulating the receptor, which is important for memory consolidation and flexibility
- influences brain development
- controls proliferation, differentiation and growth of neurites229
- responsible for memory consolidation
- increases GABA receptors in the hippocampus
- Insulin deficiency leads to diabetic neurological complications in the elderly and children
- Insulin activated phosphatidylinositol (PI)-3 kinase, which increases the externalization of DAT on the membrane surface. Chronic hypoinsulinemia, such as in diabetes, appears to reduce the available DAT on the cell surface.230 This increases extracellular dopamine and, to our understanding, should decrease phasic dopamine as less dopamine enters the cell to be stored in vesicles and released in response to signals.
6.12. Premenstrual syndrome (PMS) / Premenstrual dysphoric disorder (PMDD) (+ 143 %)
A study of 290 women with severe PMD / PMDD found increased risks for:231
- ADHD: 2.43-fold (+ 143 %)
- AuDSH: 3.27-fold (+ 227 %)
The risk for ASD without ADHD was unchanged.
6.13. Dystrophinopathy (muscular dystrophy, muscle weakness) (+ 130 %)
See under Monogenetic causes of ADHD.
6.14. Atopic disorders (excess immunoglobulin E)
Atopy is a hereditary predisposition to react hypersensitively (allergically) to environmental substances that are actually harmless.
In low birth weight infants, a history of T2 inflammatory diseases such as asthma and atopic dermatitis increased the risk of:232
- ADHD by 81 %
- Learning disability by 74 %
- ASS by 47 %
- mental disability by 35 %
Atopic disorders correlated not only with an increased risk of ADHD, but also with the severity of ASDHD symptoms.233
6.14.1. Respiratory allergies (+ 83 % to 108 %)
For the percentages in the headline, the lowest and highest results were omitted due to the sufficient number of studies.
Children with a respiratory allergy showed an ADHD prevalence of 12.16% vs. 7.63% of children without one. After adjustment for covariates, the risk increase was +50%.234
Allergic rhinitis increased the risk of ADHD
- by a factor of 3.96 (+ 296 %, OR 3.96). (METASTUDY, k = 2, n = 132,561)235
- by a factor of 2.08 (+ 108 %)236
- by a factor of 1.83 (+ 83 %; meta-analysis, k = 18, n = 4,289,444)237
- Women 1.86 times as often as men (+ 86 %)
- Children up to 8 years 1.75 times the risk of older children (+ 75%)
- ASA: 1.90-fold risk (+ 90 %)
ADHD increased the risk of allergic rhinitis
- correlatively by 1.85-fold (+ 85 %, OR 1.84) (meta-analysis, k = 10, n = 397,799)235
- correlative by 1.38-fold across all studies (+ 38 %; METASTUDY, k = 18, n = 4,289,444)237
- causally by 1.27-fold (+ 27 %) in a genetic association study238
- Allergic rhinitis was found in children with ADHD (6 to 12 years) at174
- 26.6 % of those with sleep disorders
- 13.8 % of those without sleep disorders
A review (k = 21 meta-analyses, n = 348,405,029) found with highly suggestive evidence (class II) that allergic rhinitis (hay fever) increased the risk:239
- for tic disorders by 161 % (OR 2.61)
- for sleep disorders by 171 % (OR 2.17)
6.14.2. Food allergies (+ 72 %)
A food intolerance is a reaction of the digestive system, whereas a food allergy is a reaction of the immune system.
Food allergies belong to the atopic group.240
Children with a food allergy showed an ADHD prevalence of 12.66% vs. 7.99% of children without one. After adjustment for covariates, the risk increase was +72%.234
Food allergies appear to mediate behavioral abnormalities possibly via the microbiota-gut-brain axis (MGBA) and there via gut microbiota and amino acid metabolites.241 People with food allergies show different microbiome profiles compared to non-affected individuals. Microbial interventions can support the restoration of the gut microbiome structure, e.g:242
- Nutrition
- Probiotics (living microorganisms such as bacteria and yeasts)
- Prebiotics (indigestible dietary fiber)
- Synbiotics (combination of probiotic and prebiotic)
- Fecal transplantation243244
6.14.3. Atopic eczema (+ 72 %)
Eczema increased the risk of ADHD 1.72-fold (+72%).236
6.14.4. Skin allergies (+ 65 %)
Children with a skin allergy showed an ADHD prevalence of 11.46% vs. 7.83% of children without one. After adjustment for covariates, the risk increase was +65%.234
6.14.5. Asthma (+ 34 % to + 62 %)
While respiratory allergies affect the upper airways, allergic asthma affects the lungs.
A review (k = 21 meta-analyses, n = 348,405,029) found an increase in the risk of ADHD due to asthma of 34% (OR 1.34) with convincing evidence (evidence class I).239
With highly suggestive evidence (class II), asthma increased the risk of
- Depression by 64 % (OR 1.64)
- Anxiety by 95 % (OR 1.95)
- Tic disorders by 90 % (OR 1.90),
- Suicidal thoughts by 52 % (OR 1.52)
- Suicide attempts by 60 % (OR 1.60)
- Asthma was found in children with ADHD (6 to 12 years) at174
- 10.7 % of those with sleep disorders
- 5.3 % of those without sleep disorders
A large study found an association between ADHD and asthma in children of +79% before and +62% after adjustment for all covariates. ADHD causally increased the risk of asthma in children by 27%.245
Children with bronchial asthma are more likely to have ADHD (SMD 0.29. Meta-analysis, k = 7, n = 104,975).246
A genetic association study found no causal risk increase for ADHD due to asthma238
6.14.6. Neurodermatitis / atopic dermatitis (+ 11.6 % to + 28 %)
The highest and lowest values were disregarded when determining the figures in the headline.
Neurodermatitis / atopic eczema / atopic dermatitis in childhood correlates with an increased risk of ADHD.247
A review (k = 21 meta-analyses, n = 348,405,029) found an increase in risk in atopic dermatitis with highly suggestive evidence (class II)239
- for ADHD by 28 % (OR 1.28)
- for depression by 60 % (OR 1.60)
- for anxiety by 62 % (OR 1.62)
- for suicidal thoughts by 44 % (OR 1.44)
A study in Saudi Arabia of people with ADHD found an ADHD prevalence of 20.9% in children and 18.9% in adults. Atopic dermatitis did not correlate with the severity of ADHD symptoms.248
One study found evidence that susceptibility to atopic dermatitis causally increased the risk of ADHD (+11.6%) and ASD (+13.1%). Conversely, susceptibility to ADHD (+ 11.2 %) and anorexia nervosa (+ 10 %) increased the risk of atopic dermatitis. Only the causal relationship between AD and ASD was independent of the bias due to the inverse effect.249
With urticaria, the risk of ADHD increased by 9%250
People with ADHD had a 45% increased risk of atopic dermatitis (OR = 1.45).
People with atopic dermatitis had a 34% to 42% increased risk of ADHD (OR = 1.34; HRs = 1.42), with severe atopic dermatitis the risk of ADHD was increased by 162% (OR = 2.62), with multiple allergic diseases by 189% (OR = 2.89), with atopic dermatitis and concurrent sleep disorders by 143% (ORs = 2.43). (METASTUDY, k = 49)251
In contrast, a cohort study found no significant (+2%) increased risk of ADHD in childhood atopic dermatitis.252
A cohort study of n = 69,732,807 people found an increased risk of learning difficulties (OR = 1.77) and memory problems (OR = 1.69) with atopic dermatitis.
The increase in risk was unevenly distributed: In children with neurodevelopmental disorders such as ADHD, the risk of memory or learning difficulties was increased 2 to 3-fold. In contrast, atopic dermatitis did not change the risk of learning or memory difficulties in children without neurodevelopmental disorders.253
6.15. Hyperthyroidism / hyperthyroidism (+ 70 %)
One study found a 1.7-fold prevalence of ADHD in children with hyperthyroidism.254
Children with ADHD showed
- significantly higher T4 levels (total thyroxine).255
- significantly reduced FT4 levels (free thyroxine) and TT3 levels (total triiodothyronine) (meta-analysis, k = 12, n = 11,836)256, children with ASA showed reduced FT4 and unchanged TT3.
Hyperthyroidism can cause ADHD-like symptoms, including anxiety, nervousness, irritability and physical hyperactivity. One study found a correlation between elevated TSH levels and hyperactivity in ADHD.257
In addition to other cognitive deficits, hyperthyroidism can also cause inattention and hyperarousal. Depending on the degree of hypothyroidism, the cognitive effects can range from mild impairment of memory and attention to complete dementia.258259
The THRA gene encodes the thyroid receptor alpha, TRα1, TRHB the thyroid receptor isoforms TRβ1 and TRβ2.
The pituitary hormone TSH (thyroid-stimulating hormone) stimulates the thyroid gland to produce thyroxine (T4; prohormone) and then triiodothyronine (T3). The thyroid hormones (T3 and T4) in the blood in turn regulate the pituitary release of TSH within the hypothalamic-pituitary-thyroid axis, which is mediated by the receptor isoform TRβ2.
In the case of a (rarely occurring genetic) resistance to thyroid hormone β, this negative feedback loop, which stabilizes the TH level in the blood, is disrupted. This leads to increased TH and unsuppressed, i.e. normal TSH levels.260
One cause of hyperthyroidism is Grave’s desease. The prevalence of Grave’s disease in the USA in 1972 was stated to be between 0.02 % and 0.4 %, of which 5 % was in children.261 Today, in countries with an adequate iodine supply, the prevalence is assumed to be 2% to 3% in women and 0.2% in men. Most cases occur between the ages of 30 and 60. Others report the highest incidence occurs between the ages of 11 and 15.262
There is evidence for an increased risk of ADHD in Graves’ disease.263264265 One small study reported a doubled prevalence of ADHD. One practice reports hyperactivity in 85% of the children with ADHD (n = 21), which subsided in 20 after treatment of the hyperthyroidism.266261
For the effects of abnormal thyroid hormone levels during pregnancy, see Prenatal stressors as ADHD environmental causes
6.16. Nutrition and food intolerances
6.16.1. Diet high in sugar (+ 41 %)
A diet high in refined sugar and saturated fats during childhood increased the risk of ADHD by 41%, while a healthy diet reduced the risk of ADHD by 35%. (Meta-analysis, k = 14 studies)267 Compared to a healthy diet, an unhealthy diet therefore increases the risk by 117%.
One study found a correlation between sugar intake at 30 months and the risk of ADHD, sleep disorders and anxiety. No correlation was found at the age of 12 months.268
In an Egyptian study, a child’s daily consumption of sweets correlated with a 6.82-fold risk of ADHD (+ 582%).269 Whether this is a causal cause or a consequence of changed food preferences due to the predisposition to the disorder remains to be seen.
6.16.2. Highly processed foods (up to + 25 %)
A high percentage of highly processed foods at age 3 to 4 years increased the risk of ADHD at age 12 to 13 years by 25% (RR 1.25).270
6.16.3. Commercially packaged pasta
Childhood consumption of commercially packaged pasta 3 or more times per week correlated with a 57-fold risk of ADHD.269
Whether this is related to ingredients in commercially packaged noodles in Egypt, food preferences due to ADHD, or a consequence of low family socioeconomic status is an open question.
6.16.4. Unpackaged flour
The use of unpackaged flour in cooking correlated with a 44-fold risk of ADHD in an Egyptian study.269
6.16.5. Food intolerances
A food intolerance is a reaction of the digestive system, whereas a food allergy is a reaction of the immune system.
It is certain that ADHD is not caused by individual, specific foods, phosphates or additives.
However, individual food intolerances or allergies are just as much stressors as illnesses, toxins or psychological stress and can therefore worsen the stress situation of people with ADHD to such an extent that symptoms develop. This is not a finding specific to ADHD. For example, in a group of children with schizophrenia problems, dietary treatment of an existing gluten intolerance was able to eliminate the schizophrenia symptoms in the children affected by this.271272 The same was found in people with ADHD and non-affective psychosis.273
Food additives (here: Sun yellow, carmoisine, tartrazine, ponceau 4R; quinoline yellow, allura red, sodium benzoate) can cause histamine release from circulating basophils. This is not allergic, i.e. not dependent on immunoglobulin E. The increased release of histamine can - in carriers of certain gene variants of the genes that encode histamine-degrading enzymes - increase ADHD symptoms274
To identify rare food intolerances (which, unlike allergies, cannot be detected by blood tests), an elimination diet can be helpful. However, such a diet is very difficult to implement and maintain and is barely adhered to, especially in younger children. In particular, any benefits must be weighed against the sometimes serious social consequences.
In other cases, such a diet can help to alleviate the symptoms of existing intolerances.
When assessing the effectiveness of diets (and other “desirable” therapies), parents’ assessments are often far higher than what tests or teacher evaluations can confirm.
A review (k = 21 meta-analyses, n = 348,405,029) with highly suggestive evidence (evidence class II) found an increased risk of ASA by 179% (OR 2.79) for food allergies.239
More information at ⇒ Nutrition and diet for ADHD.
6.17. Early puberty (pubertas praecox) (+ 40 %)
Among girls with early puberty (onset of sexual maturation before the age of 8 for girls and before the age of 9 for boys), the prevalence of ADHD was found to be 13.5%.275
6.18. Surgical procedures under anesthesia (+ 25 to 39 %)
Anesthesia in childhood correlates with an increased risk of ADHD276
Children who underwent a single surgical procedure under anesthesia up to the age of 5 were 37% more likely to take ADHD medication in later years.277 A Korean cohort study found a 41% increased risk of ADHD as a consequence of general anesthesia in early childhood. In addition, the duration of general anesthesia correlated with an increased risk of ADHD.278
One study found a 37% increase in the risk of ADHD with a single anesthetic during surgery up to the age of 5 years, and a 75% increase with multiple anesthetics279
A cohort study of n = 15,072 children, half of whom had received anesthetics between the ages of 0-3 years, found a 39% increased risk of ADHD.Frequency of anesthetic exposure, duration of exposure, male sex, and central nervous system surgery were significant risk factors for ADHD in the future.280
Other studies have come to similar conclusions.281282
A meta-analysis found a 25% increase in the later risk of ADHD due to general anesthesia in childhood (RR = 1.26).283
- 38 % (RR = 1.38) due to single general anesthesia of max. 60 minutes in children
- 55 % (RR = 1.55) by single general anesthesia of max. 61 to 120 minutes or more than 120 minutes in children
- 61 % (RR = 1.61) after several general anesthetics
In contrast, a cohort study in Taiwan found no increased risk of ADHD due to anesthetics in the first 3 years of life.284
It remains to be seen to what extent the probability of a surgical procedure under anesthesia is already influenced by the increased likelihood of accidents among people with ADHD. For more information, see ⇒ Consequences of ADHD.
However, there is evidence that general anesthesia using fentanyl and sevoflurane can cause ADHD symptoms in newborn mice, such as ADHD-like behaviors, cognitive impairments, fine motor skill disorders, as well as disrupt neurogenesis and alter gene expression. These could be reduced by prior administration of vitamin K2. K2 administration before general anesthesia led to significantly different gene expression changes285
6.19. Selective immunoglobulin A deficiency (+ 30 %)
Selective immunoglobulin A deficiency correlated with a 30% (OR 1.30) higher risk of ADHD and an increased incidence of respiratory and intestinal infections.286.
6.20. Inflammatory bowel disease (IBD) (+ 20 %)
Inflammatory bowel disease (IBD) correlates with an increased risk of ADHD and an increased intake of stimulants.287
People with an onset of IBD in childhood showed an increased risk of288
- ADHD: + 20 %
- ASS: + 40 %
- psychiatric disorders overall: + 60 %
- Anxiety disorders: + 90 %
- Affective disorders: + 60 %
- Eating disorders: + 60 %
- Personality disorders: + 40 %
- Suicide attempts: + 40 %
One study found no significant increase in ADHD from IBD overall, but from Crohn’s disease (CD) (+6.5%) and ulcerative colitis (UC) (+5%).289
A study of individuals with onset of IBD in childhood found a 25% reduced risk of MPH use. Ulcerative colitis was associated with a 37% reduced risk of MPH use and a reduced - although not statistically significant - risk of an ADHD diagnosis. The risk of depression was increased by 50% in IBD and by 73% in people with both IBD subtypes (Crohn’s disease and ulcerative colitis).290
Some studies suggest that IBD in the mother during pregnancy can inflame the central nervous system, which increases the risk of ADHD in the offspring.291
6.21. Antihistamines in the first years of life
A large cohort study found that taking antihistamines (especially first-generation antihistamines) in the first years of life significantly increased the risk of later ADHD. Disorder of REM sleep was cited as a possible cause, which secondarily impaired brain maturation.292
6.22. Lack of sleep
Short sleep correlated with increased risk of anxiety, attention deficit hyperactivity disorder and activity-limiting emotional and psychological states after adjusting for ethnicity, deprivation, age and gender.293
Ethnicity and socioeconomic disadvantage in the neighborhood were independently correlated with short sleep and snoring/noisy breathing during sleep.
Long sleep correlated independently with an increased risk of depression.
6.23. Acne vulgaris
One study found moderately elevated levels in adolescents (12 to 17 years) with acne vulgaris for294
- Hyperactivity
- Hyperactivity/impulsivity
- Inattention
- ADHD total score
Both acne vulgaris and ADHD are thought to be partly caused by increased androgen hormone levels in the womb.
6.24. Gut-brain axis, gut bacteria, gut flora
See under Gut-brain axis
6.25. Polycystic ovary syndrome (PCOS)
Women with polycystic ovary syndrome (PCOS) appear to have an increased risk of mental disorders, primarily anxiety disorders and depression, but also ADHD.295
Adolescents with PCOs also showed an increased risk of ADHD.296
6.26. Anabolic androgenic steroids (AAS)
Strength athletes who take anabolic androgenic steroids are significantly more likely to have ADHD than strength athletes who do not take them.297
6.27. Glucose-6-phosphate dehydrogenase deficiency (G6PD)
Glucose-6-phosphate dehydrogenase (G6PD) deficiency increased the risk of ADHD by 16%298
G6PD deficiency is an X-linked genetic disorder and affects around 4.9% of all people.
The enzyme glucose-6-phosphate dehydrogenase (G6PD) facilitates the synthesis of nicotinamide adenine dinucleotide phosphate (NADPH) and glutathione (GSH), which are involved in oxidation-reduction equilibrium regulation. G6PD deficiency causes reduced GSH levels and thus increased oxidative stress.
G6PD deficiency is mostly food-related (favism; hemolytic reaction to the consumption of fava beans) and sometimes genetic (more common in the Mediterranean region and the Middle East, partly in Asia and Africa).
G6PD deficiency can trigger (especially in children):
- severe hemolysis
- Hyperbilirubinemia
- Jaundice
- Hearing disorders
- Behavioral disorders
- lead to long-lasting neurological damage
- increased production of reactive oxygen species (ROS)
- resulting in activation of astrocytes and microglia, increased proinflammatory chemokines and cytokines, neuroinflammation, impaired brain development
- Imbalance in the antioxidant system
- this leads to impairment of astrocytes, neuronal death and DNA damage
- oxidative cell death of leukocytes, myocytes and other immunological players.
6.28. Lipodystrophy (lack of fatty tissue)
One study found evidence of a greatly increased prevalence of ADHD in lipodystrophy.299
6.29. Lipid metabolism, fatty acids
To avoid redundancies, we have placed this section under Fatty acids, probiotics and more for ADHD In the chapter Treatment: Medication for ADHD in the section Vitamins, minerals, dietary supplements for ADHD.
6.30. Gender diversity
A multinational study found evidence that the frequency and severity of ADHD symptoms was particularly high in gender-diverse individuals.300
6.31. Mitochondrial disorder
Mitochondrial dysfunction or mitochondrial disorders are being discussed as a possible cause of ADHD.301302303 So far, no concrete findings have emerged.
6.32. Diaphragmatic hernia
Among children with a congenital gap in the diaphragm (diaphragmatic hernia), 26.3%304 to 39%305 of survivors were found to have problems with sustained attention. 51.9% had a formal diagnosis of ADHD, specific learning disability or developmental disability.304
If there is a hole in the peritoneum, organs from the abdominal cavity can penetrate into the lung area and impede lung development and breathing.
The mediation pathway for ADHD is therefore hypoxia.
6.33. Factors without risk increase for ADHD
- The prevalence of microcytic anemia was found to be 14% lower in children with ADHD (OR: 0.86)306
- Growing up bilingual did not increase the risk of ADHD307
- Autoimmune diseases showed no evidence of causality of autoimmune diseases for ADHD. The study examined228
- Lupus erythematosus
- in contrast, a retrospective matched cohort study (n = 11,144) found that a lupus diagnosis after 15 years or later correlated with a 61% higher probability of psychiatric disorders and psychiatric disorders correlated with a 120% increased risk of lupus after 10 years or later. A lupus diagnosis correlated with an increased prescription of ADHD medications 10 years earlier.308
- Crohn’s disease
- Ulcerative colitis
- Type 1 diabetes (opposite study: see above)
- rheumatoid arthritis
- Psoriasis
- Ankylosing spondylitis
- Multiple sclerosis
- Lupus erythematosus
- High blood pressure
- One study found no statistical significance for a genetic link between high blood pressure and ADHD.309 This is at least countered by the main ADHD model animal, the SHR, which develops hypertension with age.
- COVID-19 gene therapy
- Gene predisposition, which makes people more susceptible to COVID-19, showed no signs of an increased risk of ADHD. Conversely, however, ADHD and Tourette’s are associated with an increased risk of COVID-19 and a more severe course of COVID-19.310
- T1w/T2w ratio
- The T1w/T2w ratio is a magnetic resonance imaging (MRI)-based indicator of intracortical myelin. There were no differences in the T1w/T2w ratio between ADHD, ASD and controls.311
- Obesity
- adjusted, there was no significant causal influence of obesity on ADHD312
- Platinum- and taxane-based chemotherapy in children313
6.34. Factors with risk reduction for ADHD
- Immigrant status of parents causes a reduced risk of ADHD314 within the first 2 generations.315
- Lyme disease correlated with a 10% reduction in ADHD prevalence316
Nudel R, Hougaard DM, Werge T, Benros ME (2023): Genetic and epidemiological analyses of infection load and its relationship with psychiatric disorders. Epidemiol Infect. 2023 May 18;151:e93. doi: 10.1017/S0950268823000687. PMID: 37197974; PMCID: PMC10311684. ↥
Lin MC, Pan YJ, Wu CS, Liu CL, Chen PC, Thompson WK, Fan CC, Wang SH (2025): Prenatal and early childhood infections requiring hospitalization and risk of neurodevelopmental disorders in offspring: a population-based birth cohort study in Taiwan. Mol Psychiatry. 2025 May;30(5):1791-1800. doi: 10.1038/s41380-024-02787-z. PMID: 39390224. ↥
Andersen M, Matthiesen NB, Murra M, Nielsen SY, Henriksen TB (2025): Early-Onset Neonatal Infection and Attention Deficit Hyperactivity and Autism Spectrum Disorder: A Nationwide Cohort Study. Paediatr Perinat Epidemiol. 2025 Sep;39(7):588-597. doi: 10.1111/ppe.70036. PMID: 40528692; PMCID: PMC12574489. n = 981.869 ↥
Hsu TW, Chu CS, Tsai SJ, Bai YM, Su TP, Chen TJ, Chen MH, Liang CS (2022): Risk of Major Mental Disorder after Severe Bacterial Infections in Children and Adolescents: A Nationwide Longitudinal Study. Neuropsychobiology. 2022;81(6):539-549. doi: 10.1159/000526984. PMID: 36404700. n = 14.024 ↥ ↥
Feigenson KA, Kusnecov AW, Silverstein SM (2014): Inflammation and the two-hit hypothesis of schizophrenia. Neurosci Biobehav Rev. 2014 Jan;38:72-93. doi: 10.1016/j.neubiorev.2013.11.006. PMID: 24247023; PMCID: PMC3896922. REVIEW ↥
Graham EE, Tetens MM, Bodilsen J, Dessau R, Ellermann-Eriksen S, Andersen NS, Jørgensen CS, Pedersen M, Søgaard KK, Bangsborg J, Nielsen AC, Møller JK, Obel D, Lebech AM, Nygaard U, Omland LH, Obel N (2024): Risk of psychiatric neurodevelopmental disorders after meningitis in childhood: a nationwide, population-based cohort study. Infect Dis (Lond). 2024 Sep 4:1-11. doi: 10.1080/23744235.2024.2399101. PMID: 39230517. n = 20.300 ↥
Wait JW, Stanton L, Schoeman JF (2002): Tuberculosis meningitis and attention deficit hyperactivity disorder in children. J Trop Pediatr. 2002 Oct;48(5):294-9. doi: 10.1093/tropej/48.5.294. PMID: 12405172. n = 42 ↥
Wait JW, Schoeman JF (2010): Behaviour profiles after tuberculous meningitis. J Trop Pediatr. 2010 Jun;56(3):166-71. doi: 10.1093/tropej/fmp080. PMID: 19710247. ↥
Mynarek M, Vik T, Andersen GL, Brigtsen AK, Hollung SJ, Larose TL, Lydersen S, Olsen LC, Strøm MS, Afset JE (2023): Mortality and neurodevelopmental outcome after invasive group B streptococcal infection in infants. Dev Med Child Neurol. 2023 Jun 12. doi: 10.1111/dmcn.15643. Epub ahead of print. PMID: 37306102. ↥ ↥
Wilson, Thomas (2022): Peridontitis as a Risk Factor for Attention Deficit Hyperactivity Disorder: Possible Neuro-inflammatory Mechanisms. Neurochem Res. 2022 Jun 28. doi: 10.1007/s11064-022-03650-9. PMID: 35764847. ↥
Lavebratt, Yang, Giacobini, Forsell, Schalling, Partonen, Gissler (2019): Early exposure to antibiotic drugs and risk for psychiatric disorders: a population-based study. Transl Psychiatry. 2019 Nov 26;9(1):317. doi: 10.1038/s41398-019-0653-9. n = 1 Mio. ↥
Oh J, Woo HG, Kim HJ, Park J, Lee M, Rahmati M, Rhee SY, Min C, Koyanagi A, Smith L, Fond G, Boyer L, Kim MS, Shin JI, Lee SW, Yon DK (2024): Prenatal and infant exposure to antibiotics and subsequent risk of neuropsychiatric disorders in children: A nationwide birth cohort study in South Korea. Psychiatry Res. 2024 Oct;340:116117. doi: 10.1016/j.psychres.2024.116117. PMID: 39128166. n = 3,2 Mio infants, 2,3 Mio mothers ↥
Li Lin CY, Huang YJ, Lin HC, Tsai ML, Ku JT, Lee FC, Chang H (2025): Increased incidence of attention-deficit/hyperactivity disorder is associated with early and prolonged exposure to antibiotics: A population-based retrospective cohort study. Pediatr Neonatol. 2025 Jun 5:S1875-9572(25)00101-9. doi: 10.1016/j.pedneo.2025.03.008. PMID: 40527658. n = 195.890 ↥
Slykerman, Thompson, Waldie, Murphy, Wall, Mitchell (2017): Antibiotics in the first year of life and subsequent neurocognitive outcomes. Acta Paediatr. 2017 Jan;106(1):87-94. doi: 10.1111/apa.13613. n = 526 ↥
Hamad, Alessi-Severini, Mahmud, Brownell, Kuo (2019): Antibiotic Exposure in the First Year of Life and the Risk of Attention-Deficit/Hyperactivity Disorder: A Population-based Cohort Study. Am J Epidemiol. 2019 Sep 5. pii: kwz178. doi: 10.1093/aje/kwz178. ↥
Axelsson, Clausen, Petersen, Hageman, Pinborg, Kessing, Bergholt, Rasmussen, Keiding, Løkkegaard (2018): Investigating the effects of cesarean delivery and antibiotic use in early childhood on risk of later attention deficit hyperactivity disorder. J Child Psychol Psychiatry. 2018 Aug 23. doi: 10.1111/jcpp.12961. n = 671.592 Geburten ↥
Beier MA, Setoguchi S, Gerhard T, Roy J, Koffman D, Mendhe D, Madej J, Strom BL, Blaser MJ, Horton DB (2025): Early childhood antibiotics and chronic pediatric conditions: a retrospective cohort study. J Infect Dis. 2025 Apr 16:jiaf191. doi: 10.1093/infdis/jiaf191. PMID: 40237450. ↥
Borrego-Ruiz A, Borrego JJ (2024): Neurodevelopmental Disorders Associated with Gut Microbiome Dysbiosis in Children. Children (Basel). 2024 Jun 28;11(7):796. doi: 10.3390/children11070796. PMID: 39062245; PMCID: PMC11275248. REVIEW ↥ ↥
Green JE, Wrobel A, Todd E, Marx W, Berk M, Lotfaliany M, Castle D, Cryan JF, Athan E, Hair C, Nierenberg AA, Jacka FN, Dawson S (2025): Early antibiotic exposure and risk of psychiatric and neurocognitive outcomes: systematic review and meta-analysis. Br J Psychiatry. 2025 Mar;226(3):171-183. doi: 10.1192/bjp.2024.121. PMID: 39658347. REVIEW ↥
Yang KL, Yen TA, Lin FJ, Hsu CN, Wang CC (2024): Antibiotic use and risk of autism spectrum disorder and attention-deficit/hyperactivity disorder: a population-based cohort study. Child Adolesc Psychiatry Ment Health. 2024 Jul 11;18(1):82. doi: 10.1186/s13034-024-00774-4. PMID: 38992772; PMCID: PMC11241894. n = 2.441.886 ↥
Greenlaw C, MacRae R, Wilson-Murphy M (2025): Powassan Virus Encephalitis in Pediatric Patients. J Child Neurol. 2025 Apr 27:8830738251333465. doi: 10.1177/08830738251333465. PMID: 40289568. ↥
Michos AG, Syriopoulou VP, Hadjichristodoulou C, Daikos GL, Lagona E, Douridas P, Mostrou G, Theodoridou M. (2007): Aseptic meningitis in children: analysis of 506 cases. PLoS One. 2007 Aug 1;2(7):e674. doi: 10.1371/journal.pone.0000674. PMID: 17668054; PMCID: PMC1933255. ↥
Fowlkes AL, Honarmand S, Glaser C, Yagi S, Schnurr D, Oberste MS, Anderson L, Pallansch MA, Khetsuriani N. (2008): Enterovirus-associated encephalitis in the California encephalitis project, 1998-2005. J Infect Dis. 2008 Dec 1;198(11):1685-91. doi: 10.1086/592988. PMID: 18959496. ↥
Balestrieri E, Matteucci C, Cipriani C, Grelli S, Ricceri L, Calamandrei G, Vallebona PS (2019): Endogenous Retroviruses Activity as a Molecular Signature of Neurodevelopmental Disorders. Int J Mol Sci. 2019 Nov 30;20(23):6050. doi: 10.3390/ijms20236050. PMID: 31801288; PMCID: PMC6928979. REVIEW ↥
(Chou IC, Lin CC, Kao CH (2015): Enterovirus Encephalitis Increases the Risk of Attention Deficit Hyperactivity Disorder: A Taiwanese Population-based Case-control Study. Medicine (Baltimore). 2015 Apr;94(16):e707. doi: 10.1097/MD.0000000000000707. PMID: 25906098; PMCID: PMC4602682. ↥
Lin HY, Chen YL, Chou PH, Gau SS, Chang LY (2022): Long-term psychiatric outcomes in youth with enterovirus A71 central nervous system involvement. Brain Behav Immun Health. 2022 Jun 1;23:100479. doi: 10.1016/j.bbih.2022.100479. PMID: 35694176; PMCID: PMC9184869. ↥
Goh M, Joy C, Gillespie AN, Soh QR, He F, Sung V (2023): Asymptomatic viruses detectable in saliva in the first year of life: a narrative review. Pediatr Res. 2023 Dec 22. doi: 10.1038/s41390-023-02952-0. PMID: 38135726. REVIEW ↥
Chang LY, Huang LM, Gau SS, Wu YY, Hsia SH, Fan TY, Lin KL, Huang YC, Lu CY, Lin TY (2007): Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med. 2007 Mar 22;356(12):1226-34. doi: 10.1056/NEJMoa065954. PMID: 17377160. ↥
Nozyce, Lee SS, Wiznia, Nachman, Mofenson, Smith, Yogev, McIntosh, Stanley, Pelton (2006): A behavioral and cognitive profile of clinically stable HIV-infected children. Pediatrics. 2006 Mar;117(3):763-70. doi: 10.1542/peds.2005-0451. PMID: 16510656. n = 274 ↥
Zeegers I, Rabie H, Swanevelder S, Edson C, Cotton M, van Toorn R (2010): Attention deficit hyperactivity and oppositional defiance disorder in HIV-infected South African children. J Trop Pediatr. 2010 Apr;56(2):97-102. doi: 10.1093/tropej/fmp072. PMID: 19656842. ↥
Dale, Church, Heyman (2003): Striatal encephalitis after varicella zoster infection complicated by Tourettism. Mov Disord. 2003 Dec;18(12):1554-6. doi: 10.1002/mds.10610. PMID: 14673900. ↥
Elmehy DA, Elmansory BM, Gamea GA, Abdelhai DI, Abd-Elsalam SM, Salamah AM, Ata DS, Mahmoud EF, Ibrahim HA, Salama AM (2023): Parasitic infections as potential risk factors for attention deficit hyperactivity disorder (ADHD) in children. J Parasit Dis. 2023 Mar;47(1):82-92. doi: 10.1007/s12639-022-01542-x. PMID: 36910322; PMCID: PMC9998788. ↥
Ogonah MGT, Botchway S, Yu R, Schofield PW, Fazel S (2025): An umbrella review of health outcomes following traumatic brain injury. Nat Ment Health. 2025;3(1):83-91. doi: 10.1038/s44220-024-00356-5. PMID: 39802934; PMCID: PMC11717692. UMBRELLASTUDY ↥ ↥
Ornstein TJ, Sagar S, Schachar RJ, Ewing-Cobbs L, Chapman SB, Dennis M, Saunders AE, Yang TT, Levin HS, Max JE (2014): Neuropsychological performance of youth with secondary attention-deficit/hyperactivity disorder 6- and 12-months after traumatic brain injury. J Int Neuropsychol Soc. 2014 Nov;20(10):971-81. doi: 10.1017/S1355617714000903. PMID: 25489810; PMCID: PMC5010863. ↥
Ryan, Catroppa, Ward, Yeates, Crossley, Hollenkamp, Hearps, Beauchamp, Anderson (2022): Association of neurostructural biomarkers with secondary attention-deficit/hyperactivity disorder (ADHD) symptom severity in children with traumatic brain injury: a prospective cohort study. Psychol Med. 2022 Aug 25:1-10. doi: 10.1017/S0033291722002598. PMID: 36004807. ↥
Kaldoja ML, Nadendla KD, Ploetz D, Caldwell CT, Suskauer SJ, Svingos A, Busch TA, Slomine BS (2025): Exploring sex differences in pediatric mild traumatic brain injury: clinical characteristics and recovery patterns of pediatric mTBI patients with non-credible effort. Child Neuropsychol. 2025 Apr 15:1-17. doi: 10.1080/09297049.2025.2492134. PMID: 40235056. ↥
Chang, Hsu, Wu, Huang, Chang, Bai, Chen, Chen (2018): Traumatic Brain Injury in Early Childhood and Risk of Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder: A Nationwide Longitudinal Study.; J Clin Psychiatry. 2018 Oct 16;79(6). pii: 17m11857. doi: 10.4088/JCP.17m11857. ↥
Vrijsen JN, Tendolkar I, Onnink M, Hoogman M, Schene AH, Fernández G, van Oostrom I, Franke B (2018): ADHD symptoms in healthy adults are associated with stressful life events and negative memory bias. Atten Defic Hyperact Disord. 2018 Jun;10(2):151-160. doi: 10.1007/s12402-017-0241-x. Epub 2017 Oct 28. PMID: 29081022; PMCID: PMC5973996. ↥
Sanchez EO, Bangasser DA (2022): The effects of early life stress on impulsivity. Neurosci Biobehav Rev. 2022 Jun;137:104638. doi: 10.1016/j.neubiorev.2022.104638. PMID: 35341796; PMCID: PMC9119952. REVIEW ↥
Karayağmurlu, Aytaç, Gülşen (2019): Relationship between otorhinologic trauma and Attention Deficit Hyperactivity Disorder symptoms in children. Int J Pediatr Otorhinolaryngol. 2019 Feb 8;120:89-92. doi: 10.1016/j.ijporl.2019.02.016. ↥
Brown AW, Esterov D, Zielinski MD, Weaver AL, Mara KC, Ferrara MJ, Immermann JM, Moir C (2023): Incidence and risk of attention-deficit/hyperactivity disorder and learning disability by adulthood after traumatic brain injury in childhood: a population-based birth cohort study. Child Neuropsychol. 2022 Oct 24:1-17. doi: 10.1080/09297049.2022.2136645. PMID: 36278854. ↥
Gerschman T, Brooks BL, Mrazik M, Eliason PH, Bonfield S, Yeates KO, Emery CA, Schneider KJ (2023): Are Self-Reported and Parent-Reported Attention Problems and Hyperactivity Associated With Higher Rates of Concussion in Youth Ice Hockey Players? Clin J Sport Med. 2022 Oct 5. doi: 10.1097/JSM.0000000000001080. PMID: 36731042. ↥
Laaksonen J, Ponkilainen V, Möttönen J, Mattila VM, Kuitunen I (2024): Paediatric traumatic brain injury and attention-deficit/hyperactivity disorder medication in Finland: a nationwide register-based cohort study. BMJ Ment Health. 2024 May 30;27(1):e301083. doi: 10.1136/bmjment-2024-301083. PMID: 39093719; PMCID: PMC11141179. n = 128.006 ↥
Cortese S, Moreno C (2025): Advancing the evidence base for child and adolescent psychopharmacology. BMJ Ment Health. 2025 Mar 3;28(1):e301634. doi: 10.1136/bmjment-2025-301634. PMID: 40032555; PMCID: PMC11877239. ↥
Almeida MN, Alper DP, Barrero C, Parikh N, Hauc SC, Moscarelli J, Golinko M, Persing J, Swanson J, Alperovich M (2024): Radiographic severity is associated with worse executive function in metopic craniosynostosis. Childs Nerv Syst. 2024 Jun 21. doi: 10.1007/s00381-024-06493-7. PMID: 38904768. ↥
Almeida MN, Alper DP, Long AS, Barrero C, Williams MC, Boroumand S, Glahn J, Shah J, Swanson J, Alperovich M (2023): Risk of ADHD, Autism Spectrum Disorder, and Executive Function Impairment in Metopic Craniosynostosis. Plast Reconstr Surg. 2023 Dec 19. doi: 10.1097/PRS.0000000000011249. PMID: 38113367. n = 60 ↥
Ihnat J, Hu KG, Goss J, Allam O, Parikh N, Vassallo M, Mayes L, Persing J, Alperovich M (2025): Long-term neurocognitive and behavioral outcomes in patients with non-syndromic craniosynostosis. Childs Nerv Syst. 2025 Jul 14;41(1):233. doi: 10.1007/s00381-025-06888-0. PMID: 40659876. n = 54 ↥
Parikh N, Hu KG, Lewis K, Kauke-Navarro M, Allam O, Goss JA, Ihnat JM, Persing JA, Golinko MS, Alperovich M (2025): Comparison of behavioral outcomes following cranial vault remodeling versus strip craniectomy for non-syndromic sagittal craniosynostosis. Childs Nerv Syst. 2025 Jul 28;41(1):248. doi: 10.1007/s00381-025-06900-7. PMID: 40719882. ↥
Vanderwiel SL, Jones B, Nickels KC, Wong-Kisiel LC, Fine A, Mandrekar J, Wirrell EC (2024): Risk of ADHD in children with childhood absence epilepsy versus controls: A population-based study. Epilepsy Behav. 2024 Dec;161:110143. doi: 10.1016/j.yebeh.2024.110143. PMID: 39515005. ↥
Brabcová DB, Otáhalová A, Kohout J, Suleková M, Mašková I, Bělohlávková A, Kršek P (2025): Quality of life, academic self-concept, and mental health in children with epilepsy: The possible role of epilepsy comorbidities. Epilepsy Behav. 2025 Sep;170:110471. doi: 10.1016/j.yebeh.2025.110471. PMID: 40383004. ↥
Wiesmüller L, Strauch D, Schönberger J, San Antonio-Arce V, Bast T, Schubert-Bast S, Syrbe S, Jacobs J, Klotz KA (2025): Sleep disturbances and health-related quality of life in children with epilepsy: A caregiver survey. Epilepsy Behav. 2025 Oct;171:110613. doi: 10.1016/j.yebeh.2025.110613. PMID: 40768929. n = 304 ↥
Teo JH, Lim WC, Wong MS, Lin JB, Han VX, Ng ZM, Thomas T (2025): Comparative clinical outcomes in children with Febrile Infection-Related Epilepsy Syndrome (FIRES). Epilepsy Behav. 2025 Sep;170:110467. doi: 10.1016/j.yebeh.2025.110467. PMID: 40382999. ↥
Perti A, Chaudhury S, Javadekar A, Mishra SR (2025): ADHD in West syndrome. Ind Psychiatry J. 2025 May-Aug;34(2):366-367. doi: 10.4103/ipj.ipj_153_24. PMID: 40861152; PMCID: PMC12373351. ↥
Silvestri R, Gagliano A, Aricò I, Calarese T, Cedro C, Bruni O, Condurso R, Germanò E, Gervasi G, Siracusano R, Vita G, Bramanti P (2009): Sleep disorders in children with Attention-Deficit/Hyperactivity Disorder (ADHD) recorded overnight by video-polysomnography. Sleep Med. 2009 Dec;10(10):1132-8. doi: 10.1016/j.sleep.2009.04.003. PMID: 19527942. ↥
Guilleminault C, Khramtsov A (2001): Upper airway resistance syndrome in children: a clinical review. Semin Pediatr Neurol. 2001 Dec;8(4):207-15. doi: 10.1053/spen.2001.29045. PMID: 11768783. REVIEW ↥ ↥ ↥ ↥ ↥ ↥ ↥
Perez A, Hunter K (2020): Adenotonsillectomy as a treatment for sleep-disordered breathing in children with ADHD. JAAPA. 2020 Oct;33(10):34-39. doi: 10.1097/01.JAA.0000697248.35685.c6. PMID: 32976233. REVIEW ↥ ↥
Abtahi S, Witmans M, Alsufyani NA, Major MP, Major PW (2020): Pediatric sleep-disordered breathing in the orthodontic population: Prevalence of positive risk and associations. Am J Orthod Dentofacial Orthop. 2020 Apr;157(4):466-473.e1. doi: 10.1016/j.ajodo.2019.05.015. PMID: 32241353. ↥ ↥ ↥
Blumer S, Eli I, Kaminsky-Kurtz S, Shreiber-Fridman Y, Dolev E, Emodi-Perlman A (2022): Sleep-Related Breathing Disorders in Children-Red Flags in Pediatric Care. J Clin Med. 2022 Sep 22;11(19):5570. doi: 10.3390/jcm11195570. PMID: 36233440; PMCID: PMC9573712. n = 227 ↥ ↥ ↥ ↥
Scalzitti NJ, Sarber KM (2018): Diagnosis and perioperative management in pediatric sleep-disordered breathing. Paediatr Anaesth. 2018 Nov;28(11):940-946. doi: 10.1111/pan.13506. PMID: 30281185. REVIEW ↥
Goodwin JL, Vasquez MM, Silva GE, Quan SF (2010): Incidence and remission of sleep-disordered breathing and related symptoms in 6- to 17-year old children–the Tucson Children’s Assessment of Sleep Apnea Study. J Pediatr. 2010 Jul;157(1):57-61. doi: 10.1016/j.jpeds.2010.01.033. PMID: 20304429; PMCID: PMC2886190. ↥ ↥
Fraire JA, Deltetto NM, Catalani F, Beneitez A, Martín L, Fischman D, Orden AB, Mayer M (2021): Prevalence of sleep-disordered breathing among adolescents and its association with the presence of obesity and hypertension. Arch Argent Pediatr. 2021 Aug;119(4):245-250. English, Spanish. doi: 10.5546/aap.2021.eng.245. PMID: 34309300. ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993): The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993 Apr 29;328(17):1230-5. doi: 10.1056/NEJM199304293281704. PMID: 8464434. ↥ ↥
Jennum P, Riha RL (2009): Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing. Eur Respir J. 2009 Apr;33(4):907-14. doi: 10.1183/09031936.00180108. PMID: 19336593. REVIEW ↥ ↥
Heinzer R, Vat S, Marques-Vidal P, Marti-Soler H, Andries D, Tobback N, Mooser V, Preisig M, Malhotra A, Waeber G, Vollenweider P, Tafti M, Haba-Rubio J (2015): Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015 Apr;3(4):310-8. doi: 10.1016/S2213-2600(15)00043-0. PMID: 25682233; PMCID: PMC4404207. n = 3.043 ↥ ↥ ↥ ↥
Matsumoto T, Chin K (2019): Prevalence of sleep disturbances: Sleep disordered breathing, short sleep duration, and non-restorative sleep. Respir Investig. 2019 May;57(3):227-237. doi: 10.1016/j.resinv.2019.01.008. PMID: 30827934. REVIEW ↥ ↥ ↥
Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, Nunez CM, Patel SR, Penzel T, Pépin JL, Peppard PE, Sinha S, Tufik S, Valentine K, Malhotra A (2019): Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019 Aug;7(8):687-698. doi: 10.1016/S2213-2600(19)30198-5. PMID: 31300334; PMCID: PMC7007763. METASTUDY ↥
Behr,M, Acker J, Cohrs S. et al. (2018):Prävalenz schlafbezogener Atmungsstörungen bei stationären Patienten mit psychischen Erkrankungen. Nervenarzt 89, 807–813 (2018). https://doi.org/10.1007/s00115-018-0545-x ↥
Gozal D, Kheirandish-Gozal L, Capdevila OS, Dayyat E, Kheirandish E (2008): Prevalence of recurrent otitis media in habitually snoring school-aged children. Sleep Med. 2008 Jul;9(5):549-54. doi: 10.1016/j.sleep.2007.08.002. PMID: 17921061; PMCID: PMC2527176. n = 1.844 ↥
Zhang QQ, Guo RX, Xie M, Qiang Y, Shi Y, Liu XH, Cheng L, Liu HQ, Luo HN (2022): Hypoxia in non-rapid eye movement sleep in children with otitis media with effusion. J Int Med Res. 2022 Oct;50(10):3000605221133659. doi: 10.1177/03000605221133659. PMID: 36310499; PMCID: PMC9619286. ↥
Huang CC, Wu PW, Chiu CH, Lee TJ, Chen CL (2022): Assessment of sleep-disordered breathing in pediatric otitis media with effusion. Pediatr Neonatol. 2022 Jan;63(1):25-32. doi: 10.1016/j.pedneo.2021.06.013. PMID: 34391662. ↥
Portier F, van den Abbeele T, Lecain E, Sauvaget E, Escoubet B, Huy PT, Herman P (1999): Oxygen modulates Na+ absorption in middle ear epithelium. Am J Physiol. 1999 Feb;276(2):C312-7. doi: 10.1152/ajpcell.1999.276.2.C312. PMID: 9950758. ↥
Bhutta MF, Cheeseman MT, Brown SD (2014): Myringotomy in the Junbo mouse model of chronic otitis media alleviates inflammation and cellular hypoxia. Laryngoscope. 2014 Sep;124(9):E377-83. doi: 10.1002/lary.24698. PMID: 24706577. ↥
Shupak A, Tabari R, Swarts JD, Bluestone CD, Doyle WJ (1996): Effects of middle ear oxygen and carbon dioxide tensions on eustachian tube ventilatory function. Laryngoscope. 1996 Feb;106(2 Pt 1):221-4. doi: 10.1097/00005537-199602000-00022. PMID: 8583858. ↥
Alshukry A, Lagier C, Della Vedova C, Salburgo F, Lavieille JP, Montava M (2020): The Effects of Hypoxia on Middle Ear Pressure Regulation. High Alt Med Biol. 2020 Mar;21(1):99-104. doi: 10.1089/ham.2019.0043. PMID: 31985271. ↥
Koyama S (1989): [Partial oxygen tension of middle ear cavity in a normobaric environment]. Nihon Jibiinkoka Gakkai Kaiho. 1989 Jan;92(1):68-77. Japanese. doi: 10.3950/jibiinkoka.92.68. PMID: 2723886. ↥
Marcus CL, Moore RH, Rosen CL, Giordani B, Garetz SL, Taylor HG, Mitchell RB, Amin R, Katz ES, Arens R, Paruthi S, Muzumdar H, Gozal D, Thomas NH, Ware J, Beebe D, Snyder K, Elden L, Sprecher RC, Willging P, Jones D, Bent JP, Hoban T, Chervin RD, Ellenberg SS, Redline S; Childhood Adenotonsillectomy Trial (CHAT). A randomized trial of adenotonsillectomy for childhood sleep apnea (2013): N Engl J Med. 2013 Jun 20;368(25):2366-76. doi: 10.1056/NEJMoa1215881. PMID: 23692173; PMCID: PMC3756808. n = 464 ↥ ↥
Bixler EO, Fernandez-Mendoza J, Liao D, Calhoun S, Rodriguez-Colon SM, Gaines J, He F, Vgontzas AN (2016): Natural history of sleep disordered breathing in prepubertal children transitioning to adolescence. Eur Respir J. 2016 May;47(5):1402-9. doi: 10.1183/13993003.01771-2015. PMID: 26846837; PMCID: PMC7085278. ↥ ↥
Tan HL, Alonso Alvarez ML, Tsaoussoglou M, Weber S, Kaditis AG (2017): When and why to treat the child who snores? Pediatr Pulmonol. 2017 Mar;52(3):399-412. doi: 10.1002/ppul.23658. PMID: 28029756. REVIEW ↥ ↥ ↥
Tabone L, Khirani S, Amaddeo A, Emeriaud G, Fauroux B (2020): Cerebral oxygenation in children with sleep-disordered breathing. Paediatr Respir Rev. 2020 Apr;34:18-23. doi: 10.1016/j.prrv.2019.10.002. PMID: 31753753. REVIEW ↥ ↥ ↥
Tabone L, Khirani S, Olmo Arroyo J, Amaddeo A, Sabil A, Fauroux B (2019): Cerebral Oxygenation During Respiratory Events in Children with Sleep-Disordered Breathing and Associated Disorders. J Pediatr. 2019 Nov;214:134-140.e7. doi: 10.1016/j.jpeds.2019.07.040. PMID: 31540763. n = 65 ↥
Tamanyan K, Weichard A, Biggs SN, Davey MJ, Nixon GM, Walter LM, Horne RSC (2019): The impact of central and obstructive respiratory events on cerebral oxygenation in children with sleep disordered breathing. Sleep. 2019 May 1;42(5):zsz044. doi: 10.1093/sleep/zsz044. PMID: 30958878. n = 60 ↥
Khadra MA, McConnell K, VanDyke R, Somers V, Fenchel M, Quadri S, Jefferies J, Cohen AP, Rutter M, Amin R (2008): Determinants of regional cerebral oxygenation in children with sleep-disordered breathing. Am J Respir Crit Care Med. 2008 Oct 15;178(8):870-5. doi: 10.1164/rccm.200802-321OC. PMID: 18658114; PMCID: PMC2566795. n = 93 ↥
Tamanyan K, Walter LM, Weichard A, Davey MJ, Nixon GM, Biggs SN, Horne RSC (2018): Age Effects on Cerebral Oxygenation and Behavior in Children with Sleep-disordered Breathing. Am J Respir Crit Care Med. 2018 Jun 1;197(11):1468-1477. doi: 10.1164/rccm.201709-1825OC. PMID: 29351000. n = 157 ↥
Pizza F, Biallas M, Wolf M, Werth E, Bassetti CL (2010): Nocturnal cerebral hemodynamics in snorers and in patients with obstructive sleep apnea: a near-infrared spectroscopy study. Sleep. 2010 Feb;33(2):205-10. doi: 10.1093/sleep/33.2.205. PMID: 20175404; PMCID: PMC2817907. n = 19 ↥
Zaffanello M, Pietrobelli A, Nosetti L, Ferrante G, Rigotti E, Ganzarolli S, Piacentini G (2025): Sleep-Disordered Breathing and Central Respiratory Control in Children: A Comprehensive Review. Children (Basel). 2025 Feb 25;12(3):279. doi: 10.3390/children12030279. PMID: 40150562; PMCID: PMC11940935. REVIEW ↥
Miano S, Paolino MC, Urbano A, Parisi P, Massolo AC, Castaldo R, Villa MP (2011): Neurocognitive assessment and sleep analysis in children with sleep-disordered breathing. Clin Neurophysiol. 2011 Feb;122(2):311-9. doi: 10.1016/j.clinph.2010.06.019. PMID: 20637692. n = 104 ↥
Smith TF, Schmidt-Kastner R, McGeary JE, Kaczorowski JA, Knopik VS (2016): Pre- and Perinatal Ischemia-Hypoxia, the Ischemia-Hypoxia Response Pathway, and ADHD Risk. Behav Genet. 2016 May;46(3):467-77. doi: 10.1007/s10519-016-9784-4. PMID: 26920003. REVIEW ↥
Ivanov I, Miraglia B, Prodanova D, Newcorn JH (2024): Sleep Disordered Breathing and Risk for ADHD: Review of Supportive Evidence and Proposed Underlying Mechanisms. J Atten Disord. 2024 Mar;28(5):686-698. doi: 10.1177/10870547241232313. PMID: 38353411. REVIEW ↥ ↥
Torabi-Nami M, Mehrabi S, Borhani-Haghighi A, Derman S (2015): Withstanding the obstructive sleep apnea syndrome at the expense of arousal instability, altered cerebral autoregulation and neurocognitive decline. J Integr Neurosci. 2015 Jun;14(2):169-93. doi: 10.1142/S0219635215500144. PMID: 25916253. REVIEW ↥
Sedky K, Bennett DS, Carvalho KS (2014): Attention deficit hyperactivity disorder and sleep disordered breathing in pediatric populations: a meta-analysis. Sleep Med Rev. 2014 Aug;18(4):349-56. doi: 10.1016/j.smrv.2013.12.003. PMID: 24581717. METASTUDY ↥
Chen F, Khorshidsavar A, Chen W, Mohtaram S (2025): Enhancing the comprehensive management strategies for attention-deficit/hyperactivity disorder (ADHD) in pediatric patients with concurrent sleep-disordered breathing: Integrating effective therapeutic approaches. Explore (NY). 2025 Nov-Dec;21(6):103241. doi: 10.1016/j.explore.2025.103241. PMID: 40865424. ↥
Hiscock H, Canterford L, Ukoumunne OC, Wake M (2007): Adverse associations of sleep problems in Australian preschoolers: national population study. Pediatrics. 2007 Jan;119(1):86-93. doi: 10.1542/peds.2006-1757. PMID: 17200274. n = 4.983 ↥ ↥
Chang SJ, Chae KY (2010): Obstructive sleep apnea syndrome in children: Epidemiology, pathophysiology, diagnosis and sequelae. Korean J Pediatr. 2010 Oct;53(10):863-71. doi: 10.3345/kjp.2010.53.10.863. PMID: 21189956; PMCID: PMC3004499. ↥
Johnson EO, Roth T (2006): An epidemiologic study of sleep-disordered breathing symptoms among adolescents. Sleep. 2006 Sep;29(9):1135-42. doi: 10.1093/sleep/29.9.1135. PMID: 17040001. ↥ ↥ ↥
Csábi E, Gaál V, Hallgató E, Schulcz RA, Katona G, Benedek P (2022): Increased behavioral problems in children with sleep-disordered breathing. Ital J Pediatr. 2022 Sep 15;48(1):173. doi: 10.1186/s13052-022-01364-w. PMID: 36109824; PMCID: PMC9479439. ↥ ↥ ↥ ↥ ↥
Melendres MC, Lutz JM, Rubin ED, Marcus CL (2004): Daytime sleepiness and hyperactivity in children with suspected sleep-disordered breathing. Pediatrics. 2004 Sep;114(3):768-75. doi: 10.1542/peds.2004-0730. PMID: 15342852. n = 180 ↥
de Carlos Villafranca F, Cobo Plana J, Díaz-Esnal B, Fernández-Mondragón P, Macías Escalada E, Puente Rodríguez M (2003): Ronchopathie chronique et syndrome de l’apnée-hypopnée obstructive du sommeil chez l’enfant [Chronic snoring and obstructive sleep apnea-hypopnea syndrome in children]. Orthod Fr. 2003 Sep;74(3):431-57. French. PMID: 15301372. ↥
Fidan T, Fidan V (2008): The impact of adenotonsillectomy on attention-deficit hyperactivity and disruptive behavioral symptoms. Eurasian J Med. 2008 Apr;40(1):14-7. PMID: 25610016; PMCID: PMC4261322. n = 30 ↥ ↥ ↥
Gottlieb DJ, Vezina RM, Chase C, Lesko SM, Heeren TC, Weese-Mayer DE, Auerbach SH, Corwin MJ (2003): Symptoms of sleep-disordered breathing in 5-year-old children are associated with sleepiness and problem behaviors. Pediatrics. 2003 Oct;112(4):870-7. doi: 10.1542/peds.112.4.870. PMID: 14523179. n = 3.019 ↥ ↥ ↥
Ali NJ, Pitson D, Stradling JR (1996): Sleep disordered breathing: effects of adenotonsillectomy on behaviour and psychological functioning. Eur J Pediatr. 1996 Jan;155(1):56-62. doi: 10.1007/BF02115629. PMID: 8750813. n = 23 ↥ ↥ ↥
Perfect MM, Archbold K, Goodwin JL, Levine-Donnerstein D, Quan SF (2013): Risk of behavioral and adaptive functioning difficulties in youth with previous and current sleep disordered breathing. Sleep. 2013 Apr 1;36(4):517-525B. doi: 10.5665/sleep.2536. PMID: 23543901; PMCID: PMC3595180. n = 263 ↥ ↥ ↥ ↥ ↥ ↥ ↥
O’Brien LM, Mervis CB, Holbrook CR, Bruner JL, Smith NH, McNally N, McClimment MC, Gozal D (2004): Neurobehavioral correlates of sleep-disordered breathing in children. J Sleep Res. 2004 Jun;13(2):165-72. doi: 10.1111/j.1365-2869.2004.00395.x. PMID: 15175097. n = 70 ↥ ↥
Gottlieb DJ, Chase C, Vezina RM, Heeren TC, Corwin MJ, Auerbach SH, Weese-Mayer DE, Lesko SM (2004): Sleep-disordered breathing symptoms are associated with poorer cognitive function in 5-year-old children. J Pediatr. 2004 Oct;145(4):458-64. doi: 10.1016/j.jpeds.2004.05.039. PMID: 15480367. n = 205 ↥ ↥ ↥
Bourke RS, Anderson V, Yang JS, Jackman AR, Killedar A, Nixon GM, Davey MJ, Walker AM, Trinder J, Horne RS (2011): Neurobehavioral function is impaired in children with all severities of sleep disordered breathing. Sleep Med. 2011 Mar;12(3):222-9. doi: 10.1016/j.sleep.2010.08.011. PMID: 21324739. n = 136 ↥ ↥ ↥
Jackman AR, Biggs SN, Walter LM, Embuldeniya US, Davey MJ, Nixon GM, Anderson V, Trinder J, Horne RS (2012): Sleep-disordered breathing in preschool children is associated with behavioral, but not cognitive, impairments. Sleep Med. 2012 Jun;13(6):621-31. doi: 10.1016/j.sleep.2012.01.013. PMID: 22503657. n = 153 ↥
Martins JG, Ladeia PO, Zechi-Ceide RM, Ribas MDC, Zimmermann N, Maximino LP (2025): Cognitive and Behavioral Characteristics of Children with Robin Sequence Associated with Stickler Syndrome: A Case Series. Cleft Palate Craniofac J. 2025 Sep 1:10556656251372323. doi: 10.1177/10556656251372323. PMID: 40888621. ↥
Wu Y, Wang C, Jiang Y, Zhang Y, Zheng L, Ning XL, Xu Z (2024): Impaired Attention in Children with Obstructive Sleep Apnea: A Preliminary Study of Behavior Combined with Neuroelectrophysiology. Nat Sci Sleep. 2024 Dec 11;16:1995-2007. doi: 10.2147/NSS.S484458. PMID: 39677824; PMCID: PMC11646427. n = 87 ↥
Koutsoklenis A, Honkasilta J (2023): ADHD in the DSM-5-TR: What has changed and what has not. Front Psychiatry. 2023 Jan 10;13:1064141. doi: 10.3389/fpsyt.2022.1064141. PMID: 36704731; PMCID: PMC9871920. ↥
Biggs SN, Nixon GM, Horne RS (2014): The conundrum of primary snoring in children: what are we missing in regards to cognitive and behavioural morbidity? Sleep Med Rev. 2014 Dec;18(6):463-75. doi: 10.1016/j.smrv.2014.06.009. PMID: 25060969. REVIEW ↥
Sadeh A, Pergamin L, Bar-Haim Y (2006): Sleep in children with attention-deficit hyperactivity disorder: a meta-analysis of polysomnographic studies. Sleep Med Rev. 2006 Dec;10(6):381-98. doi: 10.1016/j.smrv.2006.03.004. PMID: 16846743. REVIEW ↥
Konofal E, Lecendreux M, Bouvard MP, Mouren-Simeoni MC (2001): High levels of nocturnal activity in children with attention-deficit hyperactivity disorder: a video analysis. Psychiatry Clin Neurosci. 2001 Apr;55(2):97-103. doi: 10.1046/j.1440-1819.2001.00808.x. PMID: 11285086. n = 49 ↥
Carskadon MA, Pueschel SM, Millman RP (1993): Sleep-disordered breathing and behavior in three risk groups: preliminary findings from parental reports. Childs Nerv Syst. 1993 Dec;9(8):452-7. doi: 10.1007/BF00393547. PMID: 8124671. ↥
Carpena MX, Bonilla C, Matijasevich A, Martins-Silva T, Genro JP, Hutz MH, Rohde LA, Tovo-Rodrigues L (2021): Sleep-related traits and attention-deficit/hyperactivity disorder comorbidity: Shared genetic risk factors, molecular mechanisms, and causal effects. World J Biol Psychiatry. 2021 Dec;22(10):778-791. doi: 10.1080/15622975.2021.1907719. PMID: 33821771. ↥
Tomás Vila M, Miralles Torres A, Beseler Soto B, Revert Gomar M, Sala Langa MJ, Uribelarrea Sierra AI (2008): Relación entre el trastorno por déficit de atención e hiperactividad y los trastornos del sueño. Resultados de un estudio epidemiológico en la población escolar de la ciudad de Gandía [Attention-deficit/hyperactivity disorder and sleep disturbances. Results of an epidemiological study in schoolchildren in Gandia, Spain]. An Pediatr (Barc). 2008 Sep;69(3):251-7. Spanish. doi: 10.1157/13125820. PMID: 18775271. n = 877 ↥
Mir E, Kumar R, Suri TM, Suri JC, Venkatachalam VP, Sen MK, Chakrabarti S (2019): Neurocognitive and behavioral abnormalities in Indian children with sleep-disordered breathing before and after adenotonsillectomy. Lung India. 2019 Jul-Aug;36(4):304-312. doi: 10.4103/lungindia.lungindia_398_18. PMID: 31290415; PMCID: PMC6625250. ↥
Chervin RD, Ruzicka DL, Giordani BJ, Weatherly RA, Dillon JE, Hodges EK, Marcus CL, Guire KE (2006): Sleep-disordered breathing, behavior, and cognition in children before and after adenotonsillectomy. Pediatrics. 2006 Apr;117(4):e769-78. doi: 10.1542/peds.2005-1837. PMID: 16585288; PMCID: PMC1434467. n = 105 ↥
Lushington K, Kennedy D, Martin J, Kohler M (2021): Quality-of-life but not behavior improves 48-months post-adenotonsillectomy in children with SDB. Sleep Med. 2021 May;81:418-429. doi: 10.1016/j.sleep.2021.02.057. PMID: 33831667. n = 64 ↥
Song IS, Hong SN, Joo JW, Han MS, Hwang SJ, Seo MY, Lee SH (2020): Long-term results of sleep-related quality-of-life and behavioral problems after adenotonsillectomy. Laryngoscope. 2020 Feb;130(2):546-550. doi: 10.1002/lary.27951. PMID: 30950515. n = 20 ↥
Gozal D (1998): Sleep-disordered breathing and school performance in children. Pediatrics. 1998 Sep;102(3 Pt 1):616-20. doi: 10.1542/peds.102.3.616. PMID: 9738185. n = 54 ↥
Mitchell RB, Kelly J (2007): Behavioral changes in children with mild sleep-disordered breathing or obstructive sleep apnea after adenotonsillectomy. Laryngoscope. 2007 Sep;117(9):1685-8. doi: 10.1097/MLG.0b013e318093edd7. PMID: 17667138. n = 40 ↥
Mietchen JJ, Bennett DP, Huff T, Hedges DW, Gale SD (2016): Executive Function in Pediatric Sleep-Disordered Breathing: A Meta-analysis. J Int Neuropsychol Soc. 2016 Sep;22(8):839-50. doi: 10.1017/S1355617716000643. PMID: 27481012. METASTUDY ↥
Biggs SN, Bourke R, Anderson V, Jackman AR, Killedar A, Nixon GM, Davey MJ, Walker AM, Trinder J, Horne RS (2011): Working memory in children with sleep-disordered breathing: objective versus subjective measures. Sleep Med. 2011 Oct;12(9):887-91. doi: 10.1016/j.sleep.2011.07.003. PMID: 21924953. n = 127 ↥
Chervin RD, Ellenberg SS, Hou X, Marcus CL, Garetz SL, Katz ES, Hodges EK, Mitchell RB, Jones DT, Arens R, Amin R, Redline S, Rosen CL; Childhood Adenotonsillectomy Trial (2015): Prognosis for Spontaneous Resolution of OSA in Children. Chest. 2015 Nov;148(5):1204-1213. doi: 10.1378/chest.14-2873. PMID: 25811889; PMCID: PMC4631037. n = 194 ↥
Biggs SN, Walter LM, Jackman AR, Nisbet LC, Weichard AJ, Hollis SL, Davey MJ, Anderson V, Nixon GM, Horne RS (2015): Long-Term Cognitive and Behavioral Outcomes following Resolution of Sleep Disordered Breathing in Preschool Children. PLoS One. 2015 Sep 29;10(9):e0139142. doi: 10.1371/journal.pone.0139142. PMID: 26418065; PMCID: PMC4587807. n = 35 ↥
Zhang G, Spickett J, Rumchev K, Lee AH, Stick S (2004): Snoring in primary school children and domestic environment: a Perth school based study. Respir Res. 2004 Nov 4;5(1):19. doi: 10.1186/1465-9921-5-19. PMID: 15527500; PMCID: PMC535337. n = 88 ↥ ↥
Smedje H, Broman JE, Hetta J (1999): Parents’ reports of disturbed sleep in 5-7-year-old Swedish children. Acta Paediatr. 1999 Aug;88(8):858-65. doi: 10.1080/08035259950168793. PMID: 10503686. n = 1.844 ↥
Gozal D, O’Brien LM (2004): Snoring and obstructive sleep apnoea in children: why should we treat? Paediatr Respir Rev. 2004;5 Suppl A:S371-6. doi: 10.1016/s1526-0542(04)90066-8. PMID: 14980299. REVIEW ↥
Türkoğlu, Tahsin Somuk, Sapmaz, Bilgiç (2019): Effect of adenotonsillectomy on sleep problems, attention deficit hyperactivity disorder symptoms, and quality of life of children with adenotonsillar hypertrophy and sleep-disordered breathing. Int J Psychiatry Med. 2019 Mar 1:91217419829988. doi: 10.1177/0091217419829988. n = 1.736 ↥ ↥
Sahin U, Ozturk O, Ozturk M, Songur N, Bircan A, Akkaya A (2009): Habitual snoring in primary school children: prevalence and association with sleep-related disorders and school performance. Med Princ Pract. 2009;18(6):458-65. doi: 10.1159/000235895. PMID: 19797922. n = 1.164 ↥ ↥
Chervin RD, Archbold KH, Dillon JE, Panahi P, Pituch KJ, Dahl RE, Guilleminault C (2002): Inattention, hyperactivity, and symptoms of sleep-disordered breathing. Pediatrics. 2002 Mar;109(3):449-56. doi: 10.1542/peds.109.3.449. PMID: 11875140. ↥ ↥
Fatima Y, Cairns A, Skinner I, Doi SAR, Mamun AA (2018): Prenatal and early life origins of adolescence sleep problems: evidence from a birth cohort. Int J Adolesc Med Health. 2018 Oct 20;33(1). doi: 10.1515/ijamh-2018-0048. PMID: 30352032. n = 5.081 ↥ ↥ ↥ ↥
Constantin E, Low NC, Dugas E, Karp I, O’Loughlin J (2015): Association Between Childhood Sleep-Disordered Breathing and Disruptive Behavior Disorders in Childhood and Adolescence. Behav Sleep Med. 2015;13(6):442-54. doi: 10.1080/15402002.2014.940106. PMID: 25102357. n = 605 ↥ ↥ ↥ ↥
Chervin RD, Dillon JE, Bassetti C, Ganoczy DA, Pituch KJ (1997): Symptoms of sleep disorders, inattention, and hyperactivity in children. Sleep. 1997 Dec;20(12):1185-92. doi: 10.1093/sleep/20.12.1185. PMID: 9493930. n = 143 ↥ ↥
Lumeng JC, Chervin RD (2008): Epidemiology of pediatric obstructive sleep apnea. Proc Am Thorac Soc. 2008 Feb 15;5(2):242-52. doi: 10.1513/pats.200708-135MG. PMID: 18250218; PMCID: PMC2645255. REVIEW ↥
Chervin RD, Ruzicka DL, Archbold KH, Dillon JE (2005): Snoring predicts hyperactivity four years later. Sleep. 2005 Jul;28(7):885-90. doi: 10.1093/sleep/28.7.885. PMID: 16124670. n = 229 ↥
Joseph M, Lajili M, Dudoignon B, Delclaux C, Bokov P (2025): Loudness of snoring, not apnea-hypopnea index, is associated with hyperactivity behavior in snoring children and adolescents. Sleep Med. 2025 Mar;127:43-48. doi: 10.1016/j.sleep.2025.01.006. PMID: 39787820. ↥
Kim KM, Kim JH, Kim D, Lim MH, Joo H, Yoo SJ, Kim E, Ha M, Paik KC, Kwon HJ (2020): Associations among High Risk for Sleep-disordered Breathing, Related Risk Factors, and Attention Deficit/Hyperactivity Symptoms in Elementary School Children. Clin Psychopharmacol Neurosci. 2020 Nov 30;18(4):553-561. doi: 10.9758/cpn.2020.18.4.553. PMID: 33124587; PMCID: PMC7609213. n = 13.560 ↥
O’Brien LM, Mervis CB, Holbrook CR, Bruner JL, Klaus CJ, Rutherford J, Raffield TJ, Gozal D (2004): Neurobehavioral implications of habitual snoring in children. Pediatrics. 2004 Jul;114(1):44-9. doi: 10.1542/peds.114.1.44. PMID: 15231906. ↥
Wu Y, Wang Y, Wang C, Zhao F, Ma D, Xu Z, Ni X (2023): Characteristics of the Attentional Network in Children with Sleep-Disordered Breathing. Nat Sci Sleep. 2023 Sep 20;15:719-727. doi: 10.2147/NSS.S413330. PMID: 37750168; PMCID: PMC10518154. n = 95 ↥
Smith DL, Gozal D, Hunter SJ, Kheirandish-Gozal L (2017): Frequency of snoring, rather than apnea-hypopnea index, predicts both cognitive and behavioral problems in young children. Sleep Med. 2017 Jun;34:170-178. doi: 10.1016/j.sleep.2017.02.028. PMID: 28522088; PMCID: PMC5532874. n = 631 ↥
Hunter SJ, Gozal D, Smith DL, Philby MF, Kaylegian J, Kheirandish-Gozal L (2016): Effect of Sleep-disordered Breathing Severity on Cognitive Performance Measures in a Large Community Cohort of Young School-aged Children. Am J Respir Crit Care Med. 2016 Sep 15;194(6):739-47. doi: 10.1164/rccm.201510-2099OC. PMID: 26930303; PMCID: PMC5027230. n = 1.010 ↥
Brockmann PE, Bertrand P, Pardo T, Cerda J, Reyes B, Holmgren NL (2012): Prevalence of habitual snoring and associated neurocognitive consequences among Chilean school aged children. Int J Pediatr Otorhinolaryngol. 2012 Sep;76(9):1327-31. doi: 10.1016/j.ijporl.2012.05.028. PMID: 22748305. n = 523 ↥
Arman AR, Ersu R, Save D, Karadag B, Karaman G, Karabekiroglu K, Karakoc F, Dagli E, Berkem M (2005): Symptoms of inattention and hyperactivity in children with habitual snoring: evidence from a community-based study in Istanbul. Child Care Health Dev. 2005 Nov;31(6):707-17. doi: 10.1111/j.1365-2214.2005.00561.x. PMID: 16207229. n = 286 ↥ ↥ ↥
Brockmann PE, Urschitz MS, Schlaud M, Poets CF (2012): Primary snoring in school children: prevalence and neurocognitive impairments. Sleep Breath. 2012 Mar;16(1):23-9. doi: 10.1007/s11325-011-0480-6. PMID: 21240656. n = 92 ↥ ↥ ↥ ↥ ↥
Urschitz MS, Eitner S, Guenther A, Eggebrecht E, Wolff J, Urschitz-Duprat PM, Schlaud M, Poets CF (2004): Habitual snoring, intermittent hypoxia, and impaired behavior in primary school children. Pediatrics. 2004 Oct;114(4):1041-8. doi: 10.1542/peds.2003-1145-L. PMID: 15466103. n = 1.144 ↥ ↥ ↥ ↥ ↥ ↥
Liu, Liu, Liu, Sun, Jia (2019): Associations of sleep problems with ADHD symptoms: Findings from the Shandong Adolescent Behavior and Health Cohort (SABHC). Sleep. 2019 Dec 2. pii: zsz294. doi: 10.1093/sleep/zsz294. n = 7.072 ↥
Chen P, Qin J, Wang Y, Yuan J, Pan Y, Zhu B (2024): The causal relationship between sleep and risk of psychiatric disorders: A two-sample mendelian randomization study. Front Genet. 2024 Jun 17;15:1380544. doi: 10.3389/fgene.2024.1380544. PMID: 38952712; PMCID: PMC11215123. ↥
Andersson, Sonnesen (2018): Sleepiness, occlusion, dental arch and palatal dimensions in children attention deficit hyperactivity disorder (ADHD).Eur Arch Paediatr Dent. 2018 Mar 14. doi: 10.1007/s40368-018-0330-3. ↥
Chiang HL, Gau SS, Ni HC, Chiu YN, Shang CY, Wu YY, Lin LY, Tai YM, Soong WT (2010): Association between symptoms and subtypes of attention-deficit hyperactivity disorder and sleep problems/disorders. J Sleep Res. 2010 Dec;19(4):535-45. doi: 10.1111/j.1365-2869.2010.00832.x. PMID: 20408926. ↥
Rodopman-Arman A, Perdahli-Fiş N, Ekinci O, Berkem M (2011): Sleep habits, parasomnias and associated behaviors in school children with attention deficit hyperactivity disorder (ADHD). Turk J Pediatr. 2011 Jul-Aug;53(4):397-403. PMID: 21980842. ↥
Lin CH, Wu PY, Hong SY, Chang YT, Lin SS, Chou IC (2025): The Role of Polysomnography for Children with Attention-Deficit/Hyperactivity Disorder. Life (Basel). 2025 Apr 21;15(4):678. doi: 10.3390/life15040678. PMID: 40283232; PMCID: PMC12029080. n = 36 ↥
Galland BC, Tripp EG, Gray A, Taylor BJ (2011): Apnea-hypopnea indices and snoring in children diagnosed with ADHD: a matched case-control study. Sleep Breath. 2011 Sep;15(3):455-62. doi: 10.1007/s11325-010-0357-0. PMID: 20440568. ↥
Gomes AA, Parchão C, Almeida A, Clemente V, Pinto de Azevedo MH (2014): Sleep-wake patterns reported by parents in hyperactive children diagnosed according to ICD-10, as compared to paired controls. Child Psychiatry Hum Dev. 2014 Oct;45(5):533-43. doi: 10.1007/s10578-013-0422-6. PMID: 24276394. n = 30 ↥
Silvestri R, Gagliano A, Aricò I, Calarese T, Cedro C, Bruni O, Condurso R, Germanò E, Gervasi G, Siracusano R, Vita G, Bramanti P (2009): Sleep disorders in children with Attention-Deficit/Hyperactivity Disorder (ADHD) recorded overnight by video-polysomnography. Sleep Med. 2009 Dec;10(10):1132-8. doi: 10.1016/j.sleep.2009.04.003. PMID: 19527942. n = 55 ↥
Gau SS, Chiang HL (2009): Sleep problems and disorders among adolescents with persistent and subthreshold attention-deficit/hyperactivity disorders. Sleep. 2009 May;32(5):671-9. doi: 10.1093/sleep/32.5.671. PMID: 19480234; PMCID: PMC2675902. n = 466 ↥
Fatima Y, Cairns A, Skinner I, Doi SAR, Mamun AA (2018): Prenatal and early life origins of adolescence sleep problems: evidence from a birth cohort. Int J Adolesc Med Health. 2018 Oct 20;33(1). doi: 10.1515/ijamh-2018-0048. PMID: 30352032. ↥
Chiang HL, Gau SS, Ni HC, Chiu YN, Shang CY, Wu YY, Lin LY, Tai YM, Soong WT (2010): Association between symptoms and subtypes of attention-deficit hyperactivity disorder and sleep problems/disorders. J Sleep Res. 2010 Dec;19(4):535-45. doi: 10.1111/j.1365-2869.2010.00832.x. PMID: 20408926. n = 561 ↥
LeBourgeois MK, Avis K, Mixon M, Olmi J, Harsh J (2004): Snoring, sleep quality, and sleepiness across attention-deficit/hyperactivity disorder subtypes. Sleep. 2004 May 1;27(3):520-5. PMID: 15164909. n = 74 ↥
Barnes ME, Huss EA, Garrod KN, Van Raay E, Dayyat E, Gozal D, Molfese DL (2009): Impairments in attention in occasionally snoring children: an event-related potential study. Dev Neuropsychol. 2009;34(5):629-49. doi: 10.1080/87565640903133632. PMID: 20183724; PMCID: PMC3468947. n = 22 ↥
Chin WC, Huang YS, Chou YH, Wang CH, Chen KT, Hsu JF, Hsu SC (2018): Subjective and objective assessments of sleep problems in children with attention deficit/hyperactivity disorder and the effects of methylphenidate treatment. Biomed J. 2018 Dec;41(6):356-363. doi: 10.1016/j.bj.2018.10.004. PMID: 30709577; PMCID: PMC6362263. n = 101 ↥
Al-Zaabi K, Al-Adawi S, Jaju S, Jeyaseelan L, Al-Sibani N, Al-Alawi M, Al-Abri M, Al-Abri R (2018): Effects of an Adenotonsillectomy on the Cognitive and Behavioural Function of Children Who Snore: A naturalistic observational study. Sultan Qaboos Univ Med J. 2018 Nov;18(4):e455-e460. doi: 10.18295/squmj.2018.18.04.005. Epub 2019 Mar 28. PMID: 30988963; PMCID: PMC6443270. n = 37 ↥ ↥ ↥ ↥ ↥ ↥ ↥
Kohler MJ, Lushington K, van den Heuvel CJ, Martin J, Pamula Y, Kennedy D (2009): Adenotonsillectomy and neurocognitive deficits in children with Sleep Disordered Breathing. PLoS One. 2009 Oct 6;4(10):e7343. doi: 10.1371/journal.pone.0007343. PMID: 19806214; PMCID: PMC2752197. n = 92 ↥
El-Anwar MW, Hamed AA, Abdulmonaem G, Elnashar I, Elfiki IM (2017): Computed Tomography Measurement of Inferior Turbinate in Asymptomatic Adult. Int Arch Otorhinolaryngol. 2017 Oct;21(4):366-370. doi: 10.1055/s-0037-1598649. PMID: 29018500; PMCID: PMC5629090. ↥
Seeger J, Zenev E, Gundlach P, Stein T, Müller G (2003): Bipolar radiofrequency-induced thermotherapy of turbinate hypertrophy: pilot study and 20 months’ follow-up. Laryngoscope. 2003 Jan;113(1):130-5. doi: 10.1097/00005537-200301000-00024. PMID: 12514396. ↥
Ali AH, Digoy GP (2025): Exploring the Role of Turbinate Reduction in Alleviating Attention-Deficit/Hyperactivity Disorder (ADHD) Symptoms in Pediatric Patients. Cureus. 2025 Jul 26;17(7):e88807. doi: 10.7759/cureus.88807. PMID: 40861614; PMCID: PMC12377240. ↥ ↥
Deveci I, Onder S, Surmeli M, Sahin S, Kipoglu BA, Karabulut B, Eser BC (2018): Impact of Nasal Septal Surgery on Sleep Quality and Attention-Deficit/Hyperactivity Disorder. J Craniofac Surg. 2018 Oct;29(7):e632-e635. doi: 10.1097/SCS.0000000000004541. PMID: 29608471. n = 49 ↥
Benninger M, Walner D (2007): Obstructive sleep-disordered breathing in children. Clin Cornerstone. 2007;9 Suppl 1:S6-12. doi: 10.1016/s1098-3597(07)80004-4. PMID: 17584620. REVIEW ↥
Türkoğlu, Tahsin Somuk, Sapmaz, Bilgiç (2019): Effect of adenotonsillectomy on sleep problems, attention deficit hyperactivity disorder symptoms, and quality of life of children with adenotonsillar hypertrophy and sleep-disordered breathing. Int J Psychiatry Med. 2019 Mar 1:91217419829988. doi: 10.1177/0091217419829988. ↥
Kim HY, Dhong HJ, Lee JK, Chung SK, Jung SC (2011): Sleep quality and effects of position on sleep apnea in East Asian children. Auris Nasus Larynx. 2011 Apr;38(2):228-32. doi: 10.1016/j.anl.2010.07.005. PMID: 20800981. ↥
Geiger Z, Gupta N (2023): Adenoid Hypertrophy. 2023 May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30725669. ↥
Pereira L, Monyror J, Almeida FT, Almeida FR, Guerra E, Flores-Mir C, Pachêco-Pereira C (2018): Prevalence of adenoid hypertrophy: A systematic review and meta-analysis. Sleep Med Rev. 2018 Apr;38:101-112. doi: 10.1016/j.smrv.2017.06.001. PMID: 29153763. METASTUDY ↥ ↥
Kapusuz Z, Ozkırış M, Okur A, Saydam L (2012): The prevalence of adenoid hypertrophy in adults in a rural area of Turkey. Kulak Burun Bogaz Ihtis Derg. 2012 Jul-Aug;22(4):225-7. doi: 10.5606/kbbihtisas.2012.043. PMID: 22770258. ↥
Nguyen-Thi-Phuong M, Nguyen-Thi-Thanh M, Goldberg RJ, Nguyen HL, Dao-Thi-Minh A, Duong-Quy S (2025): Obstructive Sleep Apnea and Sleep Disorders in Children with Attention Deficit Hyperactivity Disorder. Pulm Ther. 2025 Sep;11(3):423-441. doi: 10.1007/s41030-025-00299-x. PMID: 40622461; PMCID: PMC12373571. n = 629 ↥ ↥ ↥ ↥ ↥
Soylu E, Soylu N, Yıldırım YS, Sakallıoğlu Ö, Polat C, Orhan I (2013): Psychiatric disorders and symptoms severity in patients with adenotonsillar hypertrophy before and after adenotonsillectomy. Int J Pediatr Otorhinolaryngol. 2013 Oct;77(10):1775-81. doi: 10.1016/j.ijporl.2013.08.020. PMID: 24011939. n = 75 ↥ ↥
Fallah R, Arabi Mianroodi A, Eslami M, Khanjani N (2020): Does Adenotonsillectomy alter Symptoms of Attention Deficit Hyperactivity Disorder in Children? Iran J Otorhinolaryngol. 2020 Nov;32(113):359-364. doi: 10.22038/ijorl.2020.43987.2456. PMID: 33282783; PMCID: PMC7701482. n = 100 ↥
Soylu E, Soylu N, Yıldırım YS, Polat C, Sakallıoğlu O (2013): The prevelance of psichiatric symptoms in preschool children with adenotonsillar hypertrophy. Int J Pediatr Otorhinolaryngol. 2013 Jul;77(7):1094-8. doi: 10.1016/j.ijporl.2013.04.005. PMID: 23643332. n = 88 ↥
Aksu H, Günel C, Özgür BG, Toka A, Başak S (2015): Effects of adenoidectomy/adenotonsillectomy on ADHD symptoms and behavioral problems in children. Int J Pediatr Otorhinolaryngol. 2015 Jul;79(7):1030-3. doi: 10.1016/j.ijporl.2015.04.018. PMID: 25933698. n = 41 ↥ ↥
Dadgarnia MH, Baradaranfar MH, Fallah R, Atighechi S, Ahsani AH, Baradaranfar A (2012): Effect of adenotonsillectomy on ADHD symptoms of children with adenotonsillar hypertrophy. Acta Med Iran. 2012;50(8):547-51. PMID: 23109027. ↥
Suratt PM, Peruggia M, D’Andrea L, Diamond R, Barth JT, Nikova M, Perriello VA Jr, Johnson ML (2006): Cognitive function and behavior of children with adenotonsillar hypertrophy suspected of having obstructive sleep-disordered breathing. Pediatrics. 2006 Sep;118(3):e771-81. doi: 10.1542/peds.2006-0173. PMID: 16894010. n = 114 ↥
Fallah R, Arabi Mianroodi A, Eslami M, Khanjani N (2020): Does Adenotonsillectomy alter Symptoms of Attention Deficit Hyperactivity Disorder in Children? Iran J Otorhinolaryngol. 2020 Nov;32(113):359-364. doi: 10.22038/ijorl.2020.43987.2456. PMID: 33282783; PMCID: PMC7701482. ↥
Amiri S, AbdollahiFakhim S, Lotfi A, Bayazian G, Sohrabpour M, Hemmatjoo T (2015): Effect of adenotonsillectomy on ADHD symptoms of children with adenotonsillar hypertrophy and sleep disordered breathing. Int J Pediatr Otorhinolaryngol. 2015 Aug;79(8):1213-7. doi: 10.1016/j.ijporl.2015.05.015. PMID: 26066853. n = 53 ↥
Wei JL, Mayo MS, Smith HJ, Reese M, Weatherly RA (2007): Improved behavior and sleep after adenotonsillectomy in children with sleep-disordered breathing. Arch Otolaryngol Head Neck Surg. 2007 Oct;133(10):974-9. doi: 10.1001/archotol.133.10.974. PMID: 17938319. n = 117 ↥
Wei JL, Bond J, Mayo MS, Smith HJ, Reese M, Weatherly RA (2009): Improved behavior and sleep after adenotonsillectomy in children with sleep-disordered breathing: long-term follow-up. Arch Otolaryngol Head Neck Surg. 2009 Jul;135(7):642-6. doi: 10.1001/archoto.2009.74. PMID: 19620583. ↥
Huang YS, Guilleminault C, Li HY, Yang CM, Wu YY, Chen NH (2007): Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study. Sleep Med. 2007 Jan;8(1):18-30. doi: 10.1016/j.sleep.2006.05.016. PMID: 17157069. ↥
Ahmadi MS, Poorolajal J, Masoomi FS, Haghighi M (2016): Effect of adenotonsillectomy on attention deficit-hyperactivity disorder in children with adenotonsillar hypertrophy: A prospective cohort study. Int J Pediatr Otorhinolaryngol. 2016 Jul;86:193-5. doi: 10.1016/j.ijporl.2016.05.012. PMID: 27260606. n = 59 ↥
Somuk BT, Bozkurt H, Göktaş G, Demir O, Gürbüzler L, Eyibilen A (2016): Impact of adenotonsillectomy on ADHD and nocturnal enuresis in children with chronic adenotonsillar hypertrophy. Am J Otolaryngol. 2016 Jan-Feb;37(1):27-30. doi: 10.1016/j.amjoto.2015.08.003. PMID: 26700255. n = 75 ↥ ↥
Ayral M, Baylan MY, Kinis V, Bez Y, Bakir S, Ozbay M, Yorgancilar E, Gun R, Topcu I (2013): Evaluation of hyperactivity, attention deficit, and impulsivity before and after adenoidectomy/adenotonsillectomy surgery. J Craniofac Surg. 2013 May;24(3):731-4. doi: 10.1097/SCS.0b013e31828011ea. PMID: 23714868. n = 63 ↥
Won DC, Guilleminault C, Koltai PJ, Quo SD, Stein MT, Loe IM (2017): It Is Just Attention-Deficit Hyperactivity Disorder…or Is It? J Dev Behav Pediatr. 2017 Feb/Mar;38(2):169-172. doi: 10.1097/DBP.0000000000000386. PMID: 28079611; PMCID: PMC5401711. n = 1 ↥
Esteller Moré E, Santos Acosta P, Segarra Isern F, Lopez Diu R, Matiño Soler E, Ademà Alcover JM, Estivill Sancho E (2012): Persistencia a largo plazo del síndrome de la apnea-hipopnea obstructiva del sueño infantil tratada con adenoamigdalectomía. Análisis de factores pronósticos [Long-term persistence of obstructive sleep apnoea-hypopnoea syndrome in children treated with adenotonsillectomy. Analysis of prognostic factors]. Acta Otorrinolaringol Esp. 2012 Mar-Apr;63(2):85-92. Spanish. doi: 10.1016/j.otorri.2011.08.004. PMID: 22342641. n = 80 ↥
DelRosso LM (2016): Epidemiology and Diagnosis of Pediatric Obstructive Sleep Apnea. Curr Probl Pediatr Adolesc Health Care. 2016 Jan;46(1):2-6. doi: 10.1016/j.cppeds.2015.10.009. PMID: 26573241. REVIEW ↥
Marcus CL (2001): Sleep-disordered breathing in children. Am J Respir Crit Care Med. 2001 Jul 1;164(1):16-30. doi: 10.1164/ajrccm.164.1.2008171. PMID: 11435234. REVIEW ↥
Akashiba T, Inoue Y, Uchimura N, Ohi M, Kasai T, Kawana F, Sakurai S, Takegami M, Tachikawa R, Tanigawa T, Chiba S, Chin K, Tsuiki S, Tonogi M, Nakamura H, Nakayama T, Narui K, Yagi T, Yamauchi M, Yamashiro Y, Yoshida M, Oga T, Tomita Y, Hamada S, Murase K, Mori H, Wada H, Uchiyama M, Ogawa H, Sato K, Nakata S, Mishima K, Momomura SI (2022): Sleep Apnea Syndrome (SAS) Clinical Practice Guidelines 2020. Respir Investig. 2022 Jan;60(1):3-32. doi: 10.1016/j.resinv.2021.08.010. PMID: 34986992. ↥ ↥
Maris M, Verhulst S, Wojciechowski M, Van de Heyning P, Boudewyns A (2016): Prevalence of Obstructive Sleep Apnea in Children with Down Syndrome. Sleep. 2016 Mar 1;39(3):699-704. doi: 10.5665/sleep.5554. PMID: 26612391; PMCID: PMC4763351. ↥
Breslin J, Spanò G, Bootzin R, Anand P, Nadel L, Edgin J (2014): Obstructive sleep apnea syndrome and cognition in Down syndrome. Dev Med Child Neurol. 2014 Jul;56(7):657-64. doi: 10.1111/dmcn.12376. PMID: 24471822. ↥
Smith, Gozal, Hunter, Kheirandish-Gozal (2017): Parent-Reported Behavioral and Psychiatric Problems Mediate the Relationship between Sleep-Disordered Breathing and Cognitive Deficits in School-Aged Children. Front Neurol. 2017 Aug 11;8:410. doi: 10.3389/fneur.2017.00410. eCollection 2017. ↥
Wu Y, Wang Y, Wang C, Zhao F, Ma D, Xu Z, Ni X (2023): Characteristics of the Attentional Network in Children with Sleep-Disordered Breathing. Nat Sci Sleep. 2023 Sep 20;15:719-727. doi: 10.2147/NSS.S413330. PMID: 37750168; PMCID: PMC10518154. n = 161 ↥
Ren Z, Qiu A (2014): Sleep-related breathing disorder is associated with hyperactivity in preschoolers. Singapore Med J. 2014 May;55(5):257-60. doi: 10.11622/smedj.2014068. PMID: 24862749; PMCID: PMC4291982. n = 110 ↥
Zhao J, Han S, Zhang J, Wang G, Wang H, Xu Z, Tai J, Peng X, Guo Y, Liu H, Tian J, Jin X, Zheng L, Zhang J, Ni X (2018): Association between mild or moderate obstructive sleep apnea-hypopnea syndrome and cognitive dysfunction in children. Sleep Med. 2018 Oct;50:132-136. doi: 10.1016/j.sleep.2018.04.009. PMID: 30036785. ↥
Cortese S, Faraone SV, Konofal E, Lecendreux M (2009): Sleep in children with attention-deficit/hyperactivity disorder: meta-analysis of subjective and objective studies. J Am Acad Child Adolesc Psychiatry. 2009 Sep;48(9):894-908. doi: 10.1097/CHI.0b013e3181ac09c9. PMID: 19625983. METASTUDY ↥
Naseem S, Chaudhary B, Collop N (2001): Attention deficit hyperactivity disorder in adults and obstructive sleep apnea. Chest. 2001 Jan;119(1):294-6. doi: 10.1378/chest.119.1.294. PMID: 11157621. ↥
Sangal RB, Owens JA, Sangal J (2005): Patients with attention-deficit/hyperactivity disorder without observed apneic episodes in sleep or daytime sleepiness have normal sleep on polysomnography. Sleep. 2005 Sep;28(9):1143-8. PMID: 16268384. n = 60 ↥
Luo G, Long F, Yi C, Zhu S, Tian Y, Li C, Long Y, Liu Z, Luo Q (2025): Changes in attention deficit and adipokine levels in children with sleep-disordered breathing. Sleep Med. 2025 Oct;134:106661. doi: 10.1016/j.sleep.2025.106661. PMID: 40752314. n = 111 ↥
Eldin MS, Alahmer M, Alkashlan E, Zahran M, Eltonsy M, Zewail A, Kasem A, Abdelaal K, Seddeek M, Ahmed Z (2023): Alterations in Inflammatory Markers and Cognitive Ability after Treatment of Pediatric Obstructive Sleep Apnea. Medicina (Kaunas). 2023 Jan 19;59(2):204. doi: 10.3390/medicina59020204. PMID: 36837406; PMCID: PMC9968190. n = 181 ↥
Taylor HG, Bowen SR, Beebe DW, Hodges E, Amin R, Arens R, Chervin RD, Garetz SL, Katz ES, Moore RH, Morales KH, Muzumdar H, Paruthi S, Rosen CL, Sadhwani A, Thomas NH, Ware J, Marcus CL, Ellenberg SS, Redline S, Giordani B (2016): Cognitive Effects of Adenotonsillectomy for Obstructive Sleep Apnea. Pediatrics. 2016 Aug;138(2):e20154458. doi: 10.1542/peds.2015-4458. PMID: 27464674; PMCID: PMC4960728. n = 453 ↥
Montgomery-Downs HE, Crabtree VM, Gozal D (2005): Cognition, sleep and respiration in at-risk children treated for obstructive sleep apnoea. Eur Respir J. 2005 Feb;25(2):336-42. doi: 10.1183/09031936.05.00082904. PMID: 15684300. n = 38 ↥
Wu D, Au VH, Yang B, Horne SJ, Weedon J, Bernstein MJ, Goldstein NA (2022): Impact of Adenotonsillectomy on Homework Performance in Children With Obstructive Sleep-Disordered Breathing. Ann Otol Rhinol Laryngol. 2022 Nov;131(11):1231-1240. doi: 10.1177/00034894211062543. PMID: 34872386. n = 163 ↥
Owens J, Spirito A, Marcotte A, McGuinn M, Berkelhammer L (2000): Neuropsychological and Behavioral Correlates of Obstructive Sleep Apnea Syndrome in Children: A Preliminary Study. Sleep Breath. 2000;4(2):67-78. doi: 10.1007/BF03045026. PMID: 11868122. n = 18 ↥ ↥ ↥ ↥ ↥
Mitchell RB, Kelly J (2005): Child behavior after adenotonsillectomy for obstructive sleep apnea syndrome. Laryngoscope. 2005 Nov;115(11):2051-5. doi: 10.1097/01.MLG.0000181516.65577.94. PMID: 16319623. ↥
Bhatt SP, Guleria R, Kabra SK (2021): Metabolic alterations and systemic inflammation in overweight/obese children with obstructive sleep apnea. PLoS One. 2021 Jun 4;16(6):e0252353. doi: 10.1371/journal.pone.0252353. PMID: 34086720; PMCID: PMC8177414. ↥
Calhoun SL, Mayes SD, Vgontzas AN, Tsaoussoglou M, Shifflett LJ, Bixler EO (2009): No relationship between neurocognitive functioning and mild sleep disordered breathing in a community sample of children. J Clin Sleep Med. 2009 Jun 15;5(3):228-34. PMID: 19960643; PMCID: PMC2699167. n = 571 ↥
Gurgel W, Garcia-Argibay M, D’Onofrio BM, Larsson H, Polanczyk GV (2025): Predictors of preschool attention-deficit/hyperactivity disorder diagnosis: a population-based study using national registers. J Child Psychol Psychiatry. 2025 Jun;66(6):834-845. doi: 10.1111/jcpp.14093. PMID: 39676220. n = 631.695 ↥
Zhou Z, Shen G, Zhou W, Gong J, Hu B (2025): Causal Relationships Between Modifiable Risk Factors and Gastroesophageal Reflux Disease: A Two-Sample Mendelian Randomization Study. Curr Med Chem. 2025 Aug 1. doi: 10.2174/0109298673372983250710031732. PMID: 40760758. n = 602.604 ↥
Bevilacqua F, Iacusso C, Aite L, Valfrè L, D’Astore M, Dotta A, Vicari S, Braguglia A, Menghini D, Conforti A, Fusaro F, Iacobelli BD (2025): Integrating psychological support in the care of children and adolescents with anorectal malformation or Hirschsprung disease: a ten-year experience. Pediatr Surg Int. 2025 Jun 24;41(1):191. doi: 10.1007/s00383-025-06073-z. PMID: 40553209. ↥
Wester T, Gunnarsdottir A, Skoglund C, Svenningsson A (2021): Attention deficit hyperactivity and autism spectrum disorders in patients with anorectal malformations. Acta Paediatr. 2021 Nov;110(11):3131-3136. doi: 10.1111/apa.16100. PMID: 34498328. n = 3.075 ↥ ↥
Yi Y, Zhong C, Wei-Wei H (2023): The long-term neurodevelopmental outcomes of febrile seizures and underlying mechanisms. Front Cell Dev Biol. 2023 May 25;11:1186050. doi: 10.3389/fcell.2023.1186050. PMID: 37305674; PMCID: PMC10248510. REVIEW ↥
Woo H, Lee SU, Yun D, Jeong S, Cho H, Kim YS (2025): Attention-deficit/hyperactivity disorder in children with a history of febrile seizures: a systematic review and meta-analysis. Eur J Pediatr. 2025 Jun 25;184(7):442. doi: 10.1007/s00431-025-06285-4. PMID: 40555878; PMCID: PMC12187803. METASTUDY ↥
Ku YC, Muo CH, Ku CS, Chen CH, Lee WY, Shen EY, Chang YJ, Kao CH (2014): Risk of subsequent attention deficit-hyperactivity disorder in children with febrile seizures. Arch Dis Child. 2014 Apr;99(4):322-6. doi: 10.1136/archdischild-2013-304647. PMID: 24307684. ↥
Bertelsen EN, Larsen JT, Petersen L, Christensen J, Dalsgaard S (2016): Childhood Epilepsy, Febrile Seizures, and Subsequent Risk of ADHD. Pediatrics. 2016 Aug;138(2):e20154654. doi: 10.1542/peds.2015-4654. PMID: 27412639. ↥
Khoshbakht Y, Bidaki R, Salehi-Abargouei A. Vitamin D Status and Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Observational Studies. Adv Nutr. 2018 Jan 1;9(1):9-20. doi: 10.1093/advances/nmx002. PMID: 29438455; PMCID: PMC6333940. METASTUDY ↥
Lancrei HM, Yeshayahu Y, Grossman ES, Berger I (2022): Sweet but sour: Impaired attention functioning in children with type 1 diabetes mellitus. Front Hum Neurosci. 2022 Sep 8;16:895835. doi: 10.3389/fnhum.2022.895835. PMID: 36158626; PMCID: PMC9495930. ↥
Chen MH, Tsai SJ, Bai YM, Huang KL, Su TP, Chen TJ, Hsu JW (2022): Type 1 diabetes mellitus and risks of major psychiatric disorders: A nationwide population-based cohort study. Diabetes Metab. 2022 Jan;48(1):101319. doi: 10.1016/j.diabet.2022.101319. PMID: 35026379. n = 68.486 ↥
Merzon, Grossman, Vinker, Merhasin, Levit, Golan-Cohen (2020): Factors associated with withdrawal from insulin pump therapy: a large-population-based study. Diabetes Metab Res Rev. 2020 Jan 10. doi: 10.1002/dmrr.3288. n = 707 ↥
Kapellen, Reimann Kiess, Kostev (2016): Prevalence of medically treated children with ADHD and type 1 diabetes in Germany – Analysis of two representative databases; J Pediatr Endocrinol Metab. 2016 Oct 18. pii: /j/jpem.ahead-of-print/jpem-2016-0171/jpem-2016-0171.xml. doi: 10.1515/jpem-2016-0171. ↥
Zhang-James Y, Draytsel D, Carguello B, Faraone SV, Weinstock RS (2025): Attention-Deficit/Hyperactivity Disorder Symptoms Are Common and Associated with Worse Glycemic Control in Adults with Type 1 Diabetes. J Clin Med. 2025 May 21;14(10):3606. doi: 10.3390/jcm14103606. PMID: 40429601; PMCID: PMC12112195. ↥
Świątek Ł, Jeske J, Miedziaszczyk M, Idasiak-Piechocka I, Wais P (2025): The effect of insulin on the central nervous system: insights into neurological complications and management of type 1 diabetes in the pediatric population. Pediatr Endocrinol Diabetes Metab. 2025;31(2):68-74. doi: 10.5114/pedm.2025.152597. PMID: 40755345; PMCID: PMC12302944. REVIEW ↥ ↥
Zhou Y, Jin B, Qiao K (2025): Investigating the causal relationships between attention-deficit/hyperactivity disorder and autoimmune diseases: Evidence from Mendelian randomization study. Medicine (Baltimore). 2025 Jan 3;104(1):e41157. doi: 10.1097/MD.0000000000041157. PMID: 40184135; PMCID: PMC11709194. ↥ ↥
Chiu SL, Cline HT (2010): Insulin receptor signaling in the development of neuronal structure and function. Neural Dev. 2010 Mar 15;5:7. doi: 10.1186/1749-8104-5-7. PMID: 20230616; PMCID: PMC2843688. REVIEW ↥
Carvelli L, Morón JA, Kahlig KM, Ferrer JV, Sen N, Lechleiter JD, Leeb-Lundberg LM, Merrill G, Lafer EM, Ballou LM, Shippenberg TS, Javitch JA, Lin RZ, Galli A (2002): PI 3-kinase regulation of dopamine uptake. J Neurochem. 2002 May;81(4):859-69. doi: 10.1046/j.1471-4159.2002.00892.x. PMID: 12065645. ↥
Kondo C, Ihara H, Ogata H, Saima S, Nakane E (2025): Association between premenstrual syndrome or premenstrual dysphoric disorder and presence of ASD or ADHD among adolescent females: a retrospective study. Arch Womens Ment Health. 2025 Jul 23. doi: 10.1007/s00737-025-01602-0. PMID: 40699321. ↥
Huang H, Zhang KP, Sun KK, Yu G (2024): Association between type 2 inflammatory diseases and neurodevelopmental disorders in low-birth-weight children and adolescents. Front Psychol. 2024 Feb 22;15:1292071. doi: 10.3389/fpsyg.2024.1292071. PMID: 38455122; PMCID: PMC10918750. n = 11.260 ↥
Chuang YC, Wang CY, Huang WL, Wang LJ, Kuo HC, Chen YC, Huang YJ (2022): Two meta-analyses of the association between atopic diseases and core symptoms of attention deficit hyperactivity disorder. Sci Rep. 2022 Mar 1;12(1):3377. doi: 10.1038/s41598-022-07232-1. PMID: 35232975; PMCID: PMC8888762. METASTUDY ↥
Xu G, Liu B, Yang W, Snetselaar LG, Chen M, Bao W, Strathearn L (2022): Association of Food Allergy, Respiratory Allergy, and Skin Allergy with Attention Deficit/Hyperactivity Disorder among Children. Nutrients. 2022 Jan 21;14(3):474. doi: 10.3390/nu14030474. PMID: 35276830; PMCID: PMC8838767. n = 192.573 ↥ ↥ ↥
Wang Q, Wang R, Li M, Liang J, Zhan X, Lu Y, Huang G, Gu Q (2024): The relationship between allergic rhinitis and attention deficit hyperactivity disorder: a systematic review and meta-analysis. PeerJ. 2024 Oct 18;12:e18287. doi: 10.7717/peerj.18287. PMID: 39434793; PMCID: PMC11493030. METASTUDY ↥ ↥
Wang LJ, Yu YH, Fu ML, Yeh WT, Hsu JL, Yang YH, Chen WJ, Chiang BL, Pan WH (2018): Attention deficit-hyperactivity disorder is associated with allergic symptoms and low levels of hemoglobin and serotonin. Sci Rep. 2018 Jul 6;8(1):10229. doi: 10.1038/s41598-018-28702-5. PMID: 29980754; PMCID: PMC6035203. ↥ ↥
Wei J, Li Y, Wu Q, Lei B, Gui X (2025): Bidirectional association between allergic rhinitis and attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. J Affect Disord. 2025 Jan 15;369:499-507. doi: 10.1016/j.jad.2024.10.032. PMID: 39389122. METASTUDY ↥ ↥ ↥ ↥ ↥
Jiang Z, Long X, Die X, Hou J, Wang Y, Wang Y, Feng W (2025): Causal effects of pediatric asthma on psychiatric disorders: a bidirectional Mendelian randomization study. J Asthma. 2025 Mar;62(3):445-455. doi: 10.1080/02770903.2024.2409418. PMID: 39320275. ↥ ↥
Xu X, Li S, Chen Y, Deng X, Li J, Xiong D, Xie H (2025): Association between allergic diseases and mental health conditions: An umbrella review. J Allergy Clin Immunol. 2025 Mar;155(3):701-713. doi: 10.1016/j.jaci.2024.10.030. PMID: 39521284. REVIEW ↥ ↥ ↥ ↥
Hu S, Li L, Zhou C, Zhang Y, Yu X (2025): Multi-Strain Probiotics Alleviate Food Allergy-Induced Neurobehavioral Abnormalities by Regulating Gut Microbiota and Metabolites. Nutrients. 2025 Jun 8;17(12):1955. doi: 10.3390/nu17121955. PMID: 40573066; PMCID: PMC12196041. ↥
Bunyavanich S, Berin MC (2019): Food allergy and the microbiome: Current understandings and future directions. J Allergy Clin Immunol. 2019 Dec;144(6):1468-1477. doi: 10.1016/j.jaci.2019.10.019. PMID: 31812181; PMCID: PMC6905201. REVIEW ↥
Maniscalco I, Bartochowski P, Priori V, Iancau SP, De Francesco M, Innamorati M, Jagodzinska N, Giupponi G, Masucci L, Conca A, Mroczek M (2025): The Effects of Fecal Microbial Transplantation on the Symptoms in Autism Spectrum Disorder, Gut Microbiota and Metabolites: A Scoping Review. Microorganisms. 2025 May 31;13(6):1290. doi: 10.3390/microorganisms13061290. PMID: 40572178; PMCID: PMC12195398. REVIEW ↥
Sharon G, Cruz NJ, Kang DW, Gandal MJ, Wang B, Kim YM, Zink EM, Casey CP, Taylor BC, Lane CJ, Bramer LM, Isern NG, Hoyt DW, Noecker C, Sweredoski MJ, Moradian A, Borenstein E, Jansson JK, Knight R, Metz TO, Lois C, Geschwind DH, Krajmalnik-Brown R, Mazmanian SK (2019): Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice. Cell. 2019 May 30;177(6):1600-1618.e17. doi: 10.1016/j.cell.2019.05.004. PMID: 31150625; PMCID: PMC6993574. ↥
Zhuoran Z, Xiaoman W, Rui Y, Qingjiu C (2025): Association Between ADHD and Pediatric Asthma: Results From a Large-Sample Cross-Sectional Study of National Surveys and Mendelian Randomization Analyses. J Atten Disord. 2025 Oct;29(12):1092-1106. doi: 10.1177/10870547251349252. PMID: 40576263. ↥
Penchev P, Milanova-Ilieva D, Gaydarski L, Petrov PP, Ketev K, Stanchev P, Husain N, Ramadanov N (2025): Attention Deficit and Memory Function in Children with Bronchial Asthma: A Systematic Review and Meta-Analysis of 104,975 Patients with Trial Sequential Analysis. Children (Basel). 2025 Jul 31;12(8):1013. doi: 10.3390/children12081013. PMID: 40868465; PMCID: PMC12384668. METASTUDY ↥
Buske-Kirschbaum, Schmitt, Plessow, Romanos, Weidinger, Roessner (2012): Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder. Psychoneuroendocrinology. 2013 Jan;38(1):12-23. doi: 10.1016/j.psyneuen.2012.09.017. PMID: 23141851. REVIEW ↥
Molla A, Jannadi R, Hafez D, Alrohaily L, Abdullah E, Azouni D, Albadrani M (2025): Exploring Attention-Deficit/Hyperactivity Disorder Symptoms in Patients With Atopic Dermatitis by Disease Severity: Cross-Sectional Analysis. JMIR Dermatol. 2025 Jul 15;8:e74126. doi: 10.2196/74126. PMID: 40663791; PMCID: PMC12283059. n = 419 ↥
Cao S, Zhang Z, Liu L, Li Y, Li W, Li Y, Wu D (2024): Causal relationships between atopic dermatitis and psychiatric disorders: a bidirectional two-sample Mendelian randomization study. BMC Psychiatry. 2024 Jan 3;24(1):16. doi: 10.1186/s12888-023-05478-1. PMID: 38172785; PMCID: PMC10763185. ↥
Liu Z, Wang Y, Wang S, Wu J, Jia C, Tan X, Liu X, Huang X, Zhang L (2024): Unraveling the causative connection between urticaria, inflammatory cytokines, and mental disorders: Perspectives from genetic evidence. Skin Res Technol. 2024 Sep;30(9):e13906. doi: 10.1111/srt.13906. PMID: 39300828; PMCID: PMC11413335. ↥
Wang HF, Liu S, Cao Y, Li QS (2025): Bidirectional association between atopic dermatitis and attention deficit hyperactivity disorder: a systematic review and meta-analysis. Ann Med. 2025 Dec;57(1):2483370. doi: 10.1080/07853890.2025.2483370. PMID: 40159827; PMCID: PMC11960313. METASTUDY ↥
Wan J, Shin DB, Syed MN, Abuabara, Lemeshow, Gelfand (2022): Atopic dermatitis and risk of major neuropsychiatric disorders in children: a population-based cohort study. J Eur Acad Dermatol Venereol. 2022 Aug 26. doi: 10.1111/jdv.18564. PMID: 36018560. n = 2,4 Mio ↥
Ma EZ, Chang HR, Radtke S, Wan J (2024): Symptoms of Cognitive Impairment Among Children With Atopic Dermatitis. JAMA Dermatol. 2024 Mar 6:e240015. doi: 10.1001/jamadermatol.2024.0015. PMID: 38446433; PMCID: PMC10918570. ↥
Zader SJ, Williams E, Buryk MA (2019); Mental Health Conditions and Hyperthyroidism. Pediatrics. 2019 Nov;144(5):e20182874. doi: 10.1542/peds.2018-2874. PMID: 31582535. n = 2.479 ↥
Ozturk Y, Hangül Z, Demir N, Tufan AE (2024): THE RELATIONS BETWEEN THYROID HORMONES AND CLINICAL FEATURES OF TURKISH CHILDREN AND ADOLESCENTS WITH ADHD AND ADHD-NOS: A PRELIMINARY STUDY. Psychiatr Danub. 2024 Dec;36(3-4):333-339. doi: 10.24869/psyd.2024.333. PMID: 39724120. n = 81 ↥
Meng H, Bigambo FM, Gu W, Wang X, Li Y (2024): Evaluation of thyroid function tests among children with neurological disorders. Front Endocrinol (Lausanne). 2024 Dec 9;15:1498788. doi: 10.3389/fendo.2024.1498788. PMID: 39717108; PMCID: PMC11663650. METASTUDY ↥
Chen G, Gao W, Xu Y, Chen H, Cai H (2023): Serum TSH Levels are Associated with Hyperactivity Behaviors in Children with Attention Deficit/Hyperactivity Disorder. Neuropsychiatr Dis Treat. 2023 Mar 7;19:557-564. doi: 10.2147/NDT.S402530. PMID: 36915908; PMCID: PMC10007977. ↥
Göbel A, Heldmann M, Göttlich M, Dirk AL, Brabant G, Münte TF (2016): Effect of Mild Thyrotoxicosis on Performance and Brain Activations in a Working Memory Task. PLoS One. 2016 Aug 18;11(8):e0161552. doi: 10.1371/journal.pone.0161552. PMID: 27536945; PMCID: PMC4990413. ↥
Bauer M, Goetz T, Glenn T, Whybrow PC (2008): The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol. 2008 Oct;20(10):1101-14. doi: 10.1111/j.1365-2826.2008.01774.x. PMID: 18673409. REVIEW ↥
Göttlich M, Chatterjee K, Moran C, Heldmann M, Rogge B, Cirkel A, Brabant G, Münte TF (2024): Altered brain functional connectivity in patients with resistance to thyroid hormone ß. PLoS One. 2024 Aug 22;19(8):e0306538. doi: 10.1371/journal.pone.0306538. PMID: 39172991; PMCID: PMC11341041. ↥
Eberle AJ (1995): Hyperactivity and Graves’ disease. J Am Acad Child Adolesc Psychiatry. 1995 Aug;34(8):973-4. doi: 10.1097/00004583-199508000-00003. PMID: 7665452. ↥ ↥
Losada-Del Pozo R, Soto-Insuga V, Martínez González M, Soriano Guillén L (2017): Neuropsychiatric manifestations of Graves’ disease in paediatric patients. Neurologia. 2017 Apr;32(3):196-197. English, Spanish. doi: 10.1016/j.nrl.2015.05.001. PMID: 26096670. ↥
Kuge R, Muroya K, Mochizuki H, Nagasaki K, Hasegawa Y (2025): Psychiatric symptoms in children and adolescents with Graves’ disease: A retrospective study and a prospective study. Pediatr Int. 2025 Jan-Dec;67(1):e70134. doi: 10.1111/ped.70134. PMID: 40599034. ↥
Bossowski AT, Reddy V, Perry LA, Johnston LB, Banerjee K, Blair JC, Savage MO (2007): Clinical and endocrine features and long-term outcome of Graves’ disease in early childhood. J Endocrinol Invest. 2007 May;30(5):388-92. doi: 10.1007/BF03346315. PMID: 17598970. ↥
Woolston JL, Caracansi A (1999): Case study: missed diagnosis and mistreatment of unrecognized comorbid Graves disease. J Am Acad Child Adolesc Psychiatry. 1999 Jul;38(7):861-4. doi: 10.1097/00004583-199907000-00016. PMID: 10405504. ↥
Sims EK, Eugster EA, Nebesio TD (2012): Detours on the road to diagnosis of Graves disease. Clin Pediatr (Phila). 2012 Feb;51(2):160-4. doi: 10.1177/0009922811418823. PMID: 21868592; PMCID: PMC4094030. ↥
Del-Ponte B, Quinte GC, Cruz S, Grellert M, Santos IS (2019): Dietary patterns and attention deficit/hyperactivity disorder (ADHD): A systematic review and meta-analysis. J Affect Disord. 2019 Jun 1;252:160-173. doi: 10.1016/j.jad.2019.04.061. PMID: 30986731. METASTUDY ↥
Voltas N, Jardí C, Hernández-Martínez C, Arija V, Canals J (2022): Association between free sugars intake and early psychopathological problems. J Child Health Care. 2022 Oct 25:13674935221135106. doi: 10.1177/13674935221135106. PMID: 36282888. n = 86 ↥
Hussein RA, Refai RH, El-Zoka AH, Azouz HG, Hussein MF (2025): Association between some environmental risk factors and attention-deficit hyperactivity disorder among children in Egypt: a case-control study. Ital J Pediatr. 2025 Jan 29;51(1):19. doi: 10.1186/s13052-025-01843-w. PMID: 39875928; PMCID: PMC11776284. n = 252 ↥ ↥ ↥
Ferreira RC, Marin AH, Vitolo MR, Campagnolo PDB (2024): Early ultra-processed foods consumption and hyperactivity/inattention in adolescence. Rev Saude Publica. 2024 Oct 18;58:46. doi: 10.11606/s1518-8787.2024058005636. Erratum in: Rev Saude Publica. 2025 Jan 17;58:46err. doi: 10.11606/s1518-8787.2024058005636err. PMID: 39442121; PMCID: PMC11548911. ↥
Niederhofer (2011): Association of Attention-Deficit/Hyperactivity Disorder and Celiac Disease: A Brief Report; Prim Care Companion CNS Disord. 2011; 13(3): PCC.10br01104; doi: 10.4088/PCC.10br01104; PMCID: PMC3184556, n = 67 ↥
ähnlich: Okusaga, Yolken, Langenberg, Sleemi, Kelly, Vaswani, Giegling, Hartmann, Konte, Friedl, Mohyuddin, Groer, Rujescu, Postolache (2013): Elevated gliadin antibody levels in individuals with schizophrenia. World J Biol Psychiatry. 2013 Sep;14(7):509-15. doi: 10.3109/15622975.2012.747699. ↥
Lachance, McKenzie (2013): Biomarkers of gluten sensitivity in patients with non-affective psychosis: a meta-analysis. Schizophr Res. 2014 Feb;152(2-3):521-7. doi: 10.1016/j.schres.2013.12.001. ↥
Stevenson J, Sonuga-Barke E, McCann D, Grimshaw K, Parker KM, Rose-Zerilli MJ, Holloway JW, Warner JO (2010): The role of histamine degradation gene polymorphisms in moderating the effects of food additives on children’s ADHD symptoms. Am J Psychiatry. 2010 Sep;167(9):1108-15. doi: 10.1176/appi.ajp.2010.09101529. PMID: 20551163. RCT ↥
Lee J, Lee SI, Lee YM, Hong YH (2023): Prevalence of Attention Deficit Hyperactivity Disorder in Girls With Central Precocious Puberty. J Atten Disord. 2023 Jul 14:10870547231180116. doi: 10.1177/10870547231180116. PMID: 37449382. ↥
Xu J, Wang F, Gao Y, Qi C, Chen T, Yan J (2024): The Relationship between Early Exposure to General Anesthesia and Neurobehavioral Deficits. Dev Neurosci. 2024 Oct 14:1-17. doi: 10.1159/000542005. PMID: 39401493. REVIEW ↥
Ing, Ma, Sun, Lu, Wall, Olfson, Li (2020): Exposure to Surgery and Anesthesia in Early Childhood and Subsequent Use of Attention Deficit Hyperactivity Disorder Medications. Anesth Analg. 2020 Jan 8. doi: 10.1213/ANE.0000000000004619. n = 256.122 ↥
Song JY, Cha HR, Lee SW, Ha EK, Kim JH, Han MY (2023): Association Between Receipt of General Anesthesia During Childhood and Attention Deficit Hyperactive Disorder and Neurodevelopment. J Korean Med Sci. 2023 Feb 13;38(6):e42. doi: 10.3346/jkms.2023.38.e42. PMID: 36786086; PMCID: PMC9925326. n = 93.717 ↥
Shi, Dykhoff, Guevara, Sangaralingham, Schroeder, Flick, Zaccariello, Warner (2021): Moderators of the association between attention-deficit/hyperactivity disorder and exposure to anaesthesia and surgery in children. Br J Anaesth. 2021 Sep 6:S0007-0912(21)00497-9. doi: 10.1016/j.bja.2021.07.025. PMID: 34503832. n = 185.002 ↥
Sun M, Chen WM, Fu S, Wu SY (2023): Zhang J. Early childhood general anesthesia and risk of Attention Deficit Hyperactivity Disorder. J Child Psychol Psychiatry. 2023 Aug 3. doi: 10.1111/jcpp.13871. PMID: 37537781. ↥
Ing, Bellinger (2022): Long-term cognitive and behavioral outcomes following early exposure to general anesthetics. Curr Opin Anaesthesiol. 2022 Jul 6. doi: 10.1097/ACO.0000000000001155. PMID: 35788121. ↥
Holst, Kronborg, Jepsen, Christensen, Vejlstrup, Juul, Bjerre, Bilenberg, Ravn (2020): Transposition of the Great Arteries, and Tetralogy of Fallot. Attention-deficit/hyperactivity disorder symptoms in children with surgically corrected Ventricular Septal Defect, Cardiol Young. 2020 Jan 13:1-8. doi: 10.1017/S1047951119003184. ↥
Zhou H, Sun W, Ning L, Kang J, Jin Y, Dong C (2024): Early exposure to general anesthesia may contribute to later attention-deficit/hyperactivity disorder (ADHD): A systematic review and meta-analysis of cohort studies. J Clin Anesth. 2024 Nov;98:111585. doi: 10.1016/j.jclinane.2024.111585. PMID: 39153353. METASTUDY ↥
Yang, Wang, Chang, Ho, Kuo (2021): A National Population Cohort Study Showed That Exposure to General Anesthesia in Early Childhood Is Associated with an Increase in the Risk of Developmental Delay. Children (Basel). 2021 Sep 24;8(10):840. doi: 10.3390/children8100840. PMID: 34682104; PMCID: PMC8534755. ↥
Hou Y, Li S, Hou Q, Wang R, Xu X, Li Z, Ma L, Liu Q, Shen Y, Zheng H (2025): Vitamin K2 mitigates cognitive, and motor impairments induced by multiple surgery with anesthesia and analgesia in neonatal stage. Biochem Biophys Res Commun. 2025 Jun 8;765:151784. doi: 10.1016/j.bbrc.2025.151784. PMID: 40273626. ↥
Merzon E, Farag R, Ashkenazi S, Magen E, Manor I, Weizman A, Green I, Golan-Cohen A, Genshin A, Vinker S, Israel A (2024): Increased Prevalence of Attention Deficit Hyperactivity Disorder in Individuals with Selective Immunoglobulin A Deficiency: A Nationwide Case-Control Study. J Clin Med. 2024 Oct 12;13(20):6075. doi: 10.3390/jcm13206075. PMID: 39458025; PMCID: PMC11508521. n = 4.632 ↥
Nadeem A, Donohue S, Shah FZ, Perez JA, Harper E, Sinh P, Padival R, Cooper G, Katz J, Cominelli F, Regueiro M, Mansoor E (2024): Early Onset Active Inflammatory Bowel Disease Is Associated With Psychiatric Comorbidities: A Multi-Network Propensity-Matched Cohort Study. Crohns Colitis 360. 2024 Dec 20;7(1):otae066. doi: 10.1093/crocol/otae066. PMID: 39749210; PMCID: PMC11694680. ↥
Butwicka A, Olén O, Larsson H, Halfvarson J, Almqvist C, Lichtenstein P, Serlachius E, Frisén L, Ludvigsson JF (2019): Association of Childhood-Onset Inflammatory Bowel Disease With Risk of Psychiatric Disorders and Suicide Attempt. JAMA Pediatr. 2019 Oct 1;173(10):969-978. doi: 10.1001/jamapediatrics.2019.2662. PMID: 31424531; PMCID: PMC6704748. ↥
Yang X, Yang L, Zhang T, Zhang H, Chen H, Zuo X (2023): Causal atlas between inflammatory bowel disease and mental disorders: a bi-directional 2-sample Mendelian randomization study. Front Immunol. 2023 Oct 13;14:1267834. doi: 10.3389/fimmu.2023.1267834. PMID: 37901213; PMCID: PMC10611497. ↥
Kappel RK, Bisgaard TH, Poulsen G, Jess T (2024): Risk of Anxiety, Depression, and Attention-Deficit/Hyperactivity Disorder in Pediatric Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study. Clin Transl Gastroenterol. 2024 Apr 1;15(4):e00657. doi: 10.14309/ctg.0000000000000657. PMID: 37934192; PMCID: PMC11042764. ↥
Shero N, Pandeya DR (2022): Impact of Crohn’s disease during pregnancy on children with attention deficit hyperactivity disorder: A review. Ann Med Surg (Lond). 2022 Feb 11;75:103369. doi: 10.1016/j.amsu.2022.103369. PMID: 35198194; PMCID: PMC8851270. REVIEW ↥
Fuhrmann, Tesch, Romanos, Abraham, Schmitt (2020): ADHD in school-age children is related to infant exposure to systemic H1-antihistamines. Allergy. 2020 Nov;75(11):2956-2957. doi: 10.1111/all.14411. PMID: 32441335. n = 41.484 ↥
Muller D, Signal TL, Shanthakumar M, Paine SJ (2023): Sleep inequities and associations between poor sleep and mental health for school-aged children: findings from the New Zealand Health Survey. Sleep Adv. 2023 Nov 18;4(1):zpad049. doi: 10.1093/sleepadvances/zpad049. PMID: 38084299; PMCID: PMC10710543. ↥
Koç HA, Önal BS (2024): Relationship between acne vulgaris and attention deficit hyperactivity disorder in adolescent: A cross-sectional study. J Dermatol. 2024 Aug 30. doi: 10.1111/1346-8138.17435. PMID: 39212308. n = 194 ↥
Rodriguez-Paris, Remlinger-Molenda, Kurzawa, Głowińska, Spaczyński, Rybakowski, Pawełczyk, Banaszewska (2019): Psychiatric disorders in women with polycystic ovary syndrome. Psychiatr Pol. 2019 Aug 31;53(4):955-966. doi: 10.12740/PP/OnlineFirst/93105. ↥
Trivedi C, Rizvi A, Ashraf S, Husain K, Yadav G, Adams E, Perugula M, Nabi S, Mansuri Z, Jain S (2024): Psychiatric Comorbidities in Hospitalized Adolescents With Polycystic Ovary Syndrome: A Cross-Sectional Study Using the National Inpatient Sample. Prim Care Companion CNS Disord. 2024 Nov 7;26(6):24m03760. doi: 10.4088/PCC.24m03760. PMID: 39546358. ↥
Kildal, Hassel, Bjørnebekk (2022): ADHD symptoms and use of anabolic androgenic steroids among male weightlifters. Sci Rep. 2022 Jun 8;12(1):9479. doi: 10.1038/s41598-022-12977-w. PMID: 35676515; PMCID: PMC9178025. ↥
Merzon E, Magen E, Ashkenazi S, Weizman A, Manor I, Krone B, Green I, Golan-Cohen A, Vinker S, Faraone SV, Israel A (2023): The Association between Glucose 6-Phosphate Dehydrogenase Deficiency and Attention Deficit/Hyperactivity Disorder. Nutrients. 2023 Nov 29;15(23):4948. doi: 10.3390/nu15234948. PMID: 38068806; PMCID: PMC10708268. ↥
Demir T, Simsir IY, Tuncel OK, Ozbaran B, Yildirim I, Pirildar S, Ozen S, Akinci B (2024): Impact of lipodystrophy on health-related quality of life: the QuaLip study. Orphanet J Rare Dis. 2024 Jan 5;19(1):10. doi: 10.1186/s13023-023-03004-w. PMID: 38183080; PMCID: PMC10768358. ↥
Lewczuk K, Marcowski P, Wizła M, Gola M, Nagy L, Koós M, Kraus SW, Demetrovics Z, Potenza MN, Ballester-Arnal R, Batthyány D, Bergeron S, Billieux J, Briken P, Burkauskas J, Cárdenas-López G, Carvalho J, Castro-Calvo J, Chen L, Ciocca G, Corazza O, Csako RI, Fernandez DP, Fujiwara H, Fernandez EF, Fuss J, Gabrhelík R, Gewirtz-Meydan A, Gjoneska B, Grubbs JB, Hashim HT, Islam MS, Ismail M, Jiménez-Martínez MC, Jurin T, Kalina O, Klein V, Költő A, Lee SK, Lin CY, Lin YC, Lochner C, López-Alvarado S, Lukavská K, Mayta-Tristán P, Miller DJ, Orosová O, Orosz G; Sungkyunkwan University’s research team; Ponce FP, Quintana GR, Quintero Garzola GC, Ramos-Diaz J, Rigaud K, Rousseau A, Tubino Scanavino M, Schulmeyer MK, Sharan P, Shibata M, Shoib S, Sigre-Leirós V, Sniewski L, Spasovski O, Steibliene V, Stein DJ, Ünsal BC, Vaillancourt-Morel MP, Claire Van Hout M, Bőthe B (2024): Cross-Cultural Adult ADHD Assessment in 42 Countries Using the Adult ADHD Self-Report Scale Screener. J Atten Disord. 2024 Feb;28(4):512-530. doi: 10.1177/10870547231215518. PMID: 38180045. ↥
Pinto Payares DV, Spooner L, Vosters J, Dominguez S, Patrick L, Harris A, Kanungo S (2024): A systematic review on the role of mitochondrial dysfunction/disorders in neurodevelopmental disorders and psychiatric/behavioral disorders. Front Psychiatry. 2024 Jun 28;15:1389093. doi: 10.3389/fpsyt.2024.1389093. PMID: 39006821; PMCID: PMC11239503. ↥
Zayats T, Johansson S, Haavik J (2015): Expanding the toolbox of ADHD genetics. How can we make sense of parent of origin effects in ADHD and related behavioral phenotypes? Behav Brain Funct. 2015 Oct 16;11(1):33. doi: 10.1186/s12993-015-0078-4. PMID: 26475699; PMCID: PMC4609130. REVIEW ↥
Yang Z, Luo Y, Yang Z, Liu Z, Li M, Wu X, Chen L, Xin W (2026): Mitochondrial dynamics dysfunction and neurodevelopmental disorders: From pathological mechanisms to clinical translation. Neural Regen Res. 2026 May 1;21(5):1926-1946. doi: 10.4103/NRR.NRR-D-24-01422. PMID: 40537021. ↥
Frisk V, Jakobson LS, Unger S, Trachsel D, O’Brien K (2011): Long-term neurodevelopmental outcomes of congenital diaphragmatic hernia survivors not treated with extracorporeal membrane oxygenation. J Pediatr Surg. 2011 Jul;46(7):1309-18. doi: 10.1016/j.jpedsurg.2010.12.023. PMID: 21763827. ↥ ↥
PEETSOLD, M., HUISMAN, J., HOFMAN, V., HEIJ, H., RAAT, H., & GEMKE, R. (2009): Psychological outcome and quality of life in children born with congenital diaphragmatic hernia. Archives of disease in childhood, 94(11), 834-840. ↥
Yackobovitch-Gavan M, Ben-Hefer D, Feldhamer I, Meyerovitch J (2024): The association between infantile microcytic anemia and attention deficit hyperactivity disorder, a case-control study. Heliyon. 2024 Jun 22;10(12):e33430. doi: 10.1016/j.heliyon.2024.e33430. PMID: 39015811; PMCID: PMC11250855. ↥
Köder F, Sharma C, Cameron S, Garraffa M (2022):The effects of bilingualism on cognition and behaviour in individuals with attention deficits: A scoping review. Front Psychol. 2022 Dec 23;13:1057501. doi: 10.3389/fpsyg.2022.1057501. PMID: 36619112; PMCID: PMC9816333. METASTUDIE ↥
Blasbalg U, Paz Toren (2024): The association between systemic lupus erythematosus (SLE) and early psychiatric background. J Psychiatr Res. 2024 Dec;180:349-354. doi: 10.1016/j.jpsychires.2024.10.029. PMID: 39520766. ↥
Huangfu N, Lu Y, Ma H, Hu Z, Cui H, Yang F (2023): Genetic liability to mental disorders in relation to the risk of hypertension. Front Cardiovasc Med. 2023 Feb 27;10:1087251. doi: 10.3389/fcvm.2023.1087251. PMID: 36923957; PMCID: PMC10008891. ↥
Chen F, Cao H, Baranova A, Zhao Q, Zhang F (2023): Causal associations between COVID-19 and childhood mental disorders. BMC Psychiatry. 2023 Dec 8;23(1):922. doi: 10.1186/s12888-023-05433-0. PMID: 38066446; PMCID: PMC10704772. ↥
Norbom LB, Syed B, Kjelkenes R, Rokicki J, Beauchamp A, Nerland S, Kushki A, Anagnostou E, Arnold P, Crosbie J, Kelley E, Nicolson R, Schachar R, Taylor MJ, Westlye LT, Tamnes CK, Lerch JP (2025): Probing Autism and ADHD subtypes using cortical signatures of the T1w/T2w-ratio and morphometry. Neuroimage Clin. 2025;45:103736. doi: 10.1016/j.nicl.2025.103736. PMID: 39837011; PMCID: PMC11788868. ↥
Zhang YX, Yang H, Guo Q, Zhang RF (2024): Investigating the causal relationship between childhood obesity and attention deficit hyperactivity disorder: A Mendelian randomization study. Asian J Surg. 2024 Dec 2:S1015-9584(24)02614-9. doi: 10.1016/j.asjsur.2024.11.012. PMID: 39627048. ↥
Van Assche IA, Van Calsteren K, Huis In ’t Veld EA, van Gerwen M, Heylen L, LeJeune CL, Cardonick E, Halaska MJ, Fruscio R, Fumagalli M, van Dijk-Lokkart EM, Lemiere J, van Grotel M, Lagae L, van den Heuvel-Eibrink MM, Amant F (2024): Child outcomes after prenatal exposure to platinum and taxane-based chemotherapy: an unplanned interim analysis of the international network on cancer, infertility, and pregnancy study. EClinicalMedicine. 2024 Nov 11;78:102922. doi: 10.1016/j.eclinm.2024.102922. PMID: 39588212; PMCID: PMC11585789. ↥
Hansen, Qureshi, Gele, Hauge, Biele, Surén, Kjøllesdal (2023): Developmental disorders among Norwegian-born children with immigrant parents. Child Adolesc Psychiatry Ment Health. 2023 Jan 6;17(1):3. doi: 10.1186/s13034-022-00547-x. PMID: 36609392; PMCID: PMC9825022. ↥
Chang J, Lee YJ, Lex H, Kerns C, Lugar K, Wright M (2023): Attention-Deficit Hyperactivity Disorder among children of immigrants: immigrant generation and family poverty. Ethn Health. 2023 Dec 17:1-13. doi: 10.1080/13557858.2023.2293657. PMID: 38105627. n = 83.362 ↥
Tetens MM, Graham EE, Andersen NS, Bangsborg J, Bodilsen J, Dessau RB, Ellermann-Eriksen S, Jørgensen CS, Møller JK, Nielsen ACY, Pedersen M, Søgaard KK, Obel D, Nygaard U, Obel N, Lebech AM, Omland LH (2025): No associations between neuroborreliosis in children and psychiatric neurodevelopmental disorders: a nationwide, population-based, matched cohort study. J Child Psychol Psychiatry. 2025 May;66(5):716-724. doi: 10.1111/jcpp.14079. PMID: 39618006. n = 12.452 ↥